Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-106b-5p BMP2 0.5 1.0E-5 0.81 0.0004 miRNATAP -0.34 7.0E-5 NA
2 hsa-miR-335-3p BMP2 0.34 0.05424 0.81 0.0004 mirMAP -0.31 0 NA
3 hsa-miR-335-5p BMP2 -1.17 0 0.81 0.0004 miRNAWalker2 validate -0.36 0 NA
4 hsa-miR-374b-5p BMP2 -0.29 0.00415 0.81 0.0004 miRNATAP -0.42 3.0E-5 NA
5 hsa-miR-378c BMP2 -1.83 0 0.81 0.0004 miRNATAP -0.21 2.0E-5 NA
6 hsa-miR-429 BMP2 0.56 0.00564 0.81 0.0004 miRNATAP -0.29 0 NA
7 hsa-miR-125a-3p BMP7 0.12 0.44483 -0.21 0.49209 miRanda -0.41 0 NA
8 hsa-miR-338-3p BMP7 -0.95 0 -0.21 0.49209 miRanda -0.21 0.00394 NA
9 hsa-miR-455-5p BMP7 1.41 0 -0.21 0.49209 miRanda -0.34 9.0E-5 NA
10 hsa-miR-495-3p BMP7 -1.48 0 -0.21 0.49209 MirTarget -0.17 0.0081 NA
11 hsa-miR-542-3p BMP7 0.64 0 -0.21 0.49209 miRanda; miRNATAP -0.31 0.00166 NA
12 hsa-let-7a-3p CTNNB1 0.1 0.42376 -0.3 0.00164 MirTarget; miRNATAP -0.13 0.00011 NA
13 hsa-miR-320a CTNNB1 0.8 0 -0.3 0.00164 PITA; miRanda; miRNATAP -0.13 2.0E-5 NA
14 hsa-miR-532-3p CTNNB1 0.8 0 -0.3 0.00164 miRNAWalker2 validate -0.14 0 NA
15 hsa-miR-7-1-3p CTNNB1 1.14 0 -0.3 0.00164 mirMAP -0.13 0 NA
16 hsa-miR-15a-5p EPB41L5 0.78 0 -0.49 9.0E-5 MirTarget -0.26 0 NA
17 hsa-miR-15b-5p EPB41L5 0.85 0 -0.49 9.0E-5 MirTarget -0.13 0.00377 NA
18 hsa-miR-16-1-3p EPB41L5 0.96 0 -0.49 9.0E-5 mirMAP -0.1 0.00499 NA
19 hsa-miR-16-2-3p EPB41L5 1.16 0 -0.49 9.0E-5 mirMAP -0.11 0.00161 NA
20 hsa-miR-17-5p EPB41L5 1.42 0 -0.49 9.0E-5 miRNAWalker2 validate -0.11 0.00058 NA
21 hsa-miR-181a-2-3p EPB41L5 0.56 5.0E-5 -0.49 9.0E-5 MirTarget -0.14 0.00037 NA
22 hsa-miR-186-5p EPB41L5 0.35 0.00015 -0.49 9.0E-5 mirMAP -0.21 0.00046 NA
23 hsa-miR-19a-3p EPB41L5 1.36 0 -0.49 9.0E-5 MirTarget; mirMAP -0.1 0.00017 NA
24 hsa-miR-19b-3p EPB41L5 0.54 0.00062 -0.49 9.0E-5 MirTarget; mirMAP -0.13 0.00019 NA
25 hsa-miR-26b-5p EPB41L5 -0.25 0.02852 -0.49 9.0E-5 mirMAP -0.14 0.00319 NA
26 hsa-miR-424-5p EPB41L5 1.48 0 -0.49 9.0E-5 MirTarget -0.11 0.00078 NA
27 hsa-miR-505-5p EPB41L5 1.26 0 -0.49 9.0E-5 MirTarget -0.12 4.0E-5 NA
28 hsa-miR-576-5p EPB41L5 0.94 0 -0.49 9.0E-5 MirTarget; PITA -0.13 0.00059 NA
29 hsa-let-7a-3p FGFR2 0.1 0.42376 -0.69 0.00028 miRNATAP -0.19 0.0051 NA
30 hsa-miR-146b-5p FGFR2 0.92 0 -0.69 0.00028 miRanda -0.32 0 NA
31 hsa-miR-186-5p FGFR2 0.35 0.00015 -0.69 0.00028 miRNAWalker2 validate -0.39 1.0E-5 NA
32 hsa-miR-193a-3p FGFR2 0.22 0.11183 -0.69 0.00028 miRanda -0.36 0 NA
33 hsa-miR-330-5p FGFR2 0.94 0 -0.69 0.00028 miRanda -0.21 0.00057 NA
34 hsa-miR-338-3p FGFR2 -0.95 0 -0.69 0.00028 miRanda; miRNATAP -0.18 0.00015 NA
35 hsa-miR-542-3p FGFR2 0.64 0 -0.69 0.00028 miRanda -0.36 0 NA
36 hsa-miR-200b-3p FOXF2 0.07 0.68286 1.77 0 TargetScan -0.28 0 25798833 The miR 200 family and the miR 183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers; We therefore identified a novel mechanism whereby the miR-200 family and the miR-183~96~182 cluster inhibit lung cancer invasion and metastasis by targeting Foxf2
37 hsa-miR-26b-5p FOXF2 -0.25 0.02852 1.77 0 miRNAWalker2 validate -0.32 3.0E-5 NA
38 hsa-miR-429 FOXF2 0.56 0.00564 1.77 0 PITA; miRanda; miRNATAP -0.16 0.00032 NA
39 hsa-miR-146b-5p GSK3B 0.92 0 0.34 0.00016 miRanda -0.13 0 NA
40 hsa-miR-155-5p GSK3B 0.53 0.00249 0.34 0.00016 miRNAWalker2 validate; miRNATAP -0.13 0 NA
41 hsa-miR-181a-5p GSK3B 0.82 0 0.34 0.00016 mirMAP -0.13 0.00022 NA
42 hsa-miR-181c-5p GSK3B -0.17 0.19695 0.34 0.00016 mirMAP -0.1 0.00092 NA
43 hsa-miR-19b-3p GSK3B 0.54 0.00062 0.34 0.00016 mirMAP -0.15 0 NA
44 hsa-miR-26b-5p GSK3B -0.25 0.02852 0.34 0.00016 miRNATAP -0.18 0 NA
45 hsa-miR-29b-3p GSK3B -0.11 0.51126 0.34 0.00016 miRTarBase; miRNATAP -0.16 0 NA
46 hsa-miR-30d-3p GSK3B -0.58 0 0.34 0.00016 miRNATAP -0.13 5.0E-5 NA
47 hsa-miR-320a GSK3B 0.8 0 0.34 0.00016 miRanda; mirMAP -0.12 3.0E-5 NA
48 hsa-miR-342-3p GSK3B 1 0 0.34 0.00016 miRanda -0.15 0 NA
49 hsa-miR-362-5p GSK3B 0.41 0.04043 0.34 0.00016 miRNATAP -0.13 0 NA
50 hsa-miR-374a-5p GSK3B -0.62 0 0.34 0.00016 mirMAP -0.15 0.00067 NA
51 hsa-miR-374b-5p GSK3B -0.29 0.00415 0.34 0.00016 mirMAP -0.23 0 NA
52 hsa-miR-664a-3p GSK3B -0.26 0.05132 0.34 0.00016 mirMAP -0.16 0 NA
53 hsa-let-7a-3p HGF 0.1 0.42376 -0.63 0.02489 mirMAP -0.68 0 NA
54 hsa-miR-141-3p HGF 0.73 0.00012 -0.63 0.02489 MirTarget; TargetScan -0.56 0 NA
55 hsa-miR-200a-3p HGF 0.61 0.0029 -0.63 0.02489 MirTarget -0.46 0 NA
56 hsa-miR-203a-3p HGF 0.04 0.88046 -0.63 0.02489 MirTarget -0.32 0 NA
57 hsa-miR-224-3p HGF 0.5 0.00811 -0.63 0.02489 mirMAP -0.38 0 NA
58 hsa-miR-26b-5p HGF -0.25 0.02852 -0.63 0.02489 MirTarget; miRNATAP -0.29 0.00556 NA
59 hsa-miR-29a-5p HGF 0.32 0.03704 -0.63 0.02489 mirMAP -0.34 2.0E-5 NA
60 hsa-miR-30b-5p HGF -0.4 0.00347 -0.63 0.02489 mirMAP -0.34 0.00014 NA
61 hsa-miR-30c-5p HGF 0.02 0.88637 -0.63 0.02489 mirMAP -0.36 1.0E-5 NA
62 hsa-miR-33a-3p HGF 0.2 0.21234 -0.63 0.02489 mirMAP -0.25 0.00127 NA
63 hsa-miR-429 HGF 0.56 0.00564 -0.63 0.02489 miRanda -0.41 0 NA
64 hsa-miR-590-5p HGF 0.76 0 -0.63 0.02489 miRanda -0.58 0 NA
65 hsa-miR-651-5p HGF 0.5 0.00156 -0.63 0.02489 MirTarget -0.32 2.0E-5 NA
66 hsa-miR-7-1-3p HGF 1.14 0 -0.63 0.02489 mirMAP -0.28 0.00052 NA
67 hsa-miR-944 HGF 1.47 0 -0.63 0.02489 mirMAP -0.33 0 NA
68 hsa-miR-106a-5p HIF1A 0.68 0.00222 0.67 0 MirTarget -0.14 0 NA
69 hsa-miR-106b-5p HIF1A 0.5 1.0E-5 0.67 0 MirTarget -0.22 4.0E-5 NA
70 hsa-miR-139-5p HIF1A -1.46 0 0.67 0 miRanda -0.15 0.00022 NA
71 hsa-miR-155-5p HIF1A 0.53 0.00249 0.67 0 MirTarget -0.17 0 NA
72 hsa-miR-16-2-3p HIF1A 1.16 0 0.67 0 MirTarget; mirMAP -0.16 0.00019 NA
73 hsa-miR-195-3p HIF1A -0.62 0.00016 0.67 0 MirTarget -0.18 0 NA
74 hsa-miR-199b-5p HIF1A -1.08 0 0.67 0 miRNAWalker2 validate; miRTarBase; MirTarget; PITA; miRanda -0.11 0.00129 NA
75 hsa-miR-20a-5p HIF1A 1.15 0 0.67 0 miRNAWalker2 validate; miRTarBase; MirTarget -0.12 0.00162 22901144 Correlation analysis showed that the key miRNAs miR-20a and miR-20b negatively correlated with the target proteins VEGF-A and HIF-1alpha
76 hsa-miR-20b-5p HIF1A 0.35 0.23201 0.67 0 miRNAWalker2 validate; miRTarBase; MirTarget -0.15 0 22901144 Correlation analysis showed that the key miRNAs miR-20a and miR-20b negatively correlated with the target proteins VEGF-A and HIF-1alpha
77 hsa-miR-217 HIF1A -1.35 0 0.67 0 miRanda -0.18 0 NA
78 hsa-miR-320a HIF1A 0.8 0 0.67 0 miRanda -0.23 0 NA
79 hsa-miR-338-3p HIF1A -0.95 0 0.67 0 MirTarget; PITA; miRanda -0.19 0 NA
80 hsa-miR-582-3p HIF1A -0.25 0.1438 0.67 0 PITA -0.23 0 NA
81 hsa-miR-582-5p HIF1A -0.04 0.82183 0.67 0 MirTarget; PITA; miRNATAP -0.22 0 NA
82 hsa-miR-660-5p HIF1A -0.2 0.10109 0.67 0 MirTarget -0.3 0 NA
83 hsa-miR-93-5p HIF1A 1.61 0 0.67 0 MirTarget -0.14 0.00035 NA
84 hsa-let-7a-5p HMGA2 -0.44 3.0E-5 4.46 0 miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan -0.77 1.0E-5 20949044; 18413822; 23073586; 21598109; 24612219; 23134218; 23700794; 21412931 Since let-7 miRNAs generally play a tumor-suppressive role as targeting oncogenes such as RAS and HMGA2 our results suggest that AZ-P7a cells release let-7 miRNAs via exosomes into the extracellular environment to maintain their oncogenesis;Recent studies report that HMGA2 is negatively regulated by the let-7 microRNA miRNA family; However no studies have examined the clinical significance of HMGA2 and its relationship to the let-7 miRNA family in gastric cancer; We also did an association study comparing HMGA2 expression and let-7 miRNA family expression in gastric cancer; An inverse correlation between HMGA2 and let-7a was found in gastric cancer cell lines P = 0.08; Furthermore our findings suggest that HMGA2 is negatively regulated by the let-7 miRNA family in human gastric cancer;HMGA2 mRNA and let-7 family microRNA were detected by real time fluorescent quantitative reverse transcription polymerase chain reaction in the corresponding frozen tissues; All let-7 family members were detectable in all ovarian cancer samples and their expression were inversely correlated with HMGA2 mRNA expression r=-0.305P<0.05; The downregulation of let-7 is but not the only mechanism of HMGA2 overexpression in serous ovarian cancer;Role of microRNA let 7 and effect to HMGA2 in esophageal squamous cell carcinoma; To investigated the role of microRNA miRNA let-7 and its regulation on high mobility group A2 HMGA2 protein expression in esophageal squamous cell carcinoma ESCC; To evaluate the role of let-7 and HMGA2 cell proliferations were analyzed with synthetic let-7 mimics- or its inhibitor-transfected cells; The transcription of let-7 inversely correlated with HMGA2 protein; The present results demonstrated that let-7 and HMGA2 involved in ESCC carcinogenesis;HMGA2 is down regulated by microRNA let 7 and associated with epithelial mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs; To investigate the expression of let-7 and its regulation of high-mobility group A2 protein HMGA2 and to verify the relationship between let-7 HMGA2 and the process of epithelial-mesenchymal transition EMT in oesophageal squamous cell carcinomas OSCC of Kazakh patients; Let-7 could repress expression of HMGA2 after co-transfection with let-7 and HMGA2 P = 0.002; Moreover let-7 expression was observed less frequently P = 2.0 × 10-8 and HMGA2 expression more frequently P = 1.0 × 10-10 in OSCC than in normal adjacent tissues; and let-7 expression was observed less frequently in OSCC from Kazakh patients than in those from Han and Uygur patients P = 0.041; There was a reverse correlation between expression of let-7 and HMGA2 P = 0.018; Expression of let-7 can suppress cell proliferation by acting directly on regulation of HMGA2 in OSCC;MicroRNA let 7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K Ras and HMGA2 gene expression; K-RAS and HMGA2 mRNA levels were significantly higher in the let-7a overexpressed group than those in the let-7a inhibited group p < 0.05; However the protein levels of K-RAS and HMGA2 were significantly lower in the let-7a overexpressed group than those in the let-7a inhibited group p < 0.05; We suppose that let-7a inhibits the proliferation and invasion of the cell line 95D by regulating the translation of K-RAS and HMGA2 mRNA not the transcription of the mRNA itself;MiR-98 a member in the let-7 family acts as a negative regulator in the expression of HMGA2 high mobility group A2 oncogene and it has been shown to have a nearly 3-fold decrease in A549/DDP cells;Let 7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data; The aim of our study was first to assess the role of HMGA2 expression in the pathogenesis of adipocytic tumors AT and second to seek a potential correlation between overexpression of HMGA2 and let-7 expression inhibition by analyzing a series of 56 benign and malignant AT with molecular cytogenetic data; We measured the levels of expression of HMGA2 mRNA and of eight members of the let-7 microRNA family using quantitative RT-PCR and expression of HMGA2 protein using immunohistochemistry; Although overexpression of both HMGA2 mRNA and protein in a majority of ordinary lipomas without HMGA2 structural rearrangement may have suggested a potential role for let-7 microRNAs we did not observe a significant link with let-7 inhibition in such cases
85 hsa-let-7b-5p HMGA2 -0.25 0.02114 4.46 0 miRNAWalker2 validate; miRTarBase; MirTarget -0.69 4.0E-5 20949044; 18413822; 23073586; 21598109; 24612219; 23700794; 21412931 Since let-7 miRNAs generally play a tumor-suppressive role as targeting oncogenes such as RAS and HMGA2 our results suggest that AZ-P7a cells release let-7 miRNAs via exosomes into the extracellular environment to maintain their oncogenesis;Recent studies report that HMGA2 is negatively regulated by the let-7 microRNA miRNA family; However no studies have examined the clinical significance of HMGA2 and its relationship to the let-7 miRNA family in gastric cancer; We also did an association study comparing HMGA2 expression and let-7 miRNA family expression in gastric cancer; Furthermore our findings suggest that HMGA2 is negatively regulated by the let-7 miRNA family in human gastric cancer;HMGA2 mRNA and let-7 family microRNA were detected by real time fluorescent quantitative reverse transcription polymerase chain reaction in the corresponding frozen tissues; All let-7 family members were detectable in all ovarian cancer samples and their expression were inversely correlated with HMGA2 mRNA expression r=-0.305P<0.05; The downregulation of let-7 is but not the only mechanism of HMGA2 overexpression in serous ovarian cancer;Role of microRNA let 7 and effect to HMGA2 in esophageal squamous cell carcinoma; To investigated the role of microRNA miRNA let-7 and its regulation on high mobility group A2 HMGA2 protein expression in esophageal squamous cell carcinoma ESCC; To evaluate the role of let-7 and HMGA2 cell proliferations were analyzed with synthetic let-7 mimics- or its inhibitor-transfected cells; The transcription of let-7 inversely correlated with HMGA2 protein; The present results demonstrated that let-7 and HMGA2 involved in ESCC carcinogenesis;HMGA2 is down regulated by microRNA let 7 and associated with epithelial mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs; To investigate the expression of let-7 and its regulation of high-mobility group A2 protein HMGA2 and to verify the relationship between let-7 HMGA2 and the process of epithelial-mesenchymal transition EMT in oesophageal squamous cell carcinomas OSCC of Kazakh patients; Let-7 could repress expression of HMGA2 after co-transfection with let-7 and HMGA2 P = 0.002; Moreover let-7 expression was observed less frequently P = 2.0 × 10-8 and HMGA2 expression more frequently P = 1.0 × 10-10 in OSCC than in normal adjacent tissues; and let-7 expression was observed less frequently in OSCC from Kazakh patients than in those from Han and Uygur patients P = 0.041; There was a reverse correlation between expression of let-7 and HMGA2 P = 0.018; Expression of let-7 can suppress cell proliferation by acting directly on regulation of HMGA2 in OSCC;MiR-98 a member in the let-7 family acts as a negative regulator in the expression of HMGA2 high mobility group A2 oncogene and it has been shown to have a nearly 3-fold decrease in A549/DDP cells;Let 7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data; The aim of our study was first to assess the role of HMGA2 expression in the pathogenesis of adipocytic tumors AT and second to seek a potential correlation between overexpression of HMGA2 and let-7 expression inhibition by analyzing a series of 56 benign and malignant AT with molecular cytogenetic data; We measured the levels of expression of HMGA2 mRNA and of eight members of the let-7 microRNA family using quantitative RT-PCR and expression of HMGA2 protein using immunohistochemistry; Although overexpression of both HMGA2 mRNA and protein in a majority of ordinary lipomas without HMGA2 structural rearrangement may have suggested a potential role for let-7 microRNAs we did not observe a significant link with let-7 inhibition in such cases
86 hsa-let-7c-5p HMGA2 -2.08 0 4.46 0 miRNAWalker2 validate; miRTarBase; MirTarget -0.81 0 NA
87 hsa-let-7f-5p HMGA2 -0.44 0.00243 4.46 0 miRNAWalker2 validate; MirTarget -0.35 0.00531 NA
88 hsa-let-7g-5p HMGA2 -0.25 0.0094 4.46 0 miRNAWalker2 validate; miRTarBase; MirTarget -0.75 8.0E-5 21472347; 18308936 Furthermore K-Ras and HMGA2 are well known as targets of let-7g; In this study we evaluated the potential role of precursor pre-let-7g in lung cancer cell metastasis focusing on the two targets of let-7g HMGA2 and K-Ras;In let-7g expressing tumors reductions in Ras family and HMGA2 protein levels were detected; Ectopic expression of K-RasG12D largely rescued let-7g mediated tumor suppression whereas ectopic expression of HMGA2 was less effective
89 hsa-miR-125b-2-3p HMGA2 -1.88 0 4.46 0 mirMAP -0.6 0 NA
90 hsa-miR-125b-5p HMGA2 -0.99 0 4.46 0 miRNAWalker2 validate; miRTarBase -0.87 0 NA
91 hsa-miR-148a-5p HMGA2 -1 0 4.46 0 mirMAP -0.52 0 NA
92 hsa-miR-195-3p HMGA2 -0.62 0.00016 4.46 0 mirMAP -0.73 0 NA
93 hsa-miR-195-5p HMGA2 -1.84 0 4.46 0 MirTarget -0.82 0 NA
94 hsa-miR-199a-5p HMGA2 -0.36 0.04351 4.46 0 miRanda -0.28 0.00611 NA
95 hsa-miR-199b-5p HMGA2 -1.08 0 4.46 0 miRanda -0.41 6.0E-5 NA
96 hsa-miR-20b-5p HMGA2 0.35 0.23201 4.46 0 miRNATAP -0.31 0 NA
97 hsa-miR-23b-3p HMGA2 -0.5 3.0E-5 4.46 0 mirMAP -1.07 0 NA
98 hsa-miR-26a-5p HMGA2 -1.09 0 4.46 0 miRNAWalker2 validate; miRTarBase; miRNATAP -1.05 0 24682444 Furthermore we demonstrated that high mobility group AT-hook 2 HMGA2 was a direct target of miR-26a; The results showed that HMGA2 mRNA levels and miR-26a levels were negatively correlated; In addition we confirmed that reintroduction of HMGA2 antagonized the inhibition of miR-26a to GBC cell proliferation and all these effects were achieved through the cell cycle; Together all these results suggest that miR-26a expression contributes to GBC proliferation by targeting HMGA2 miR-26a shows promise as a prognosis factor and therapeutic target of GBC patients
99 hsa-miR-29b-2-5p HMGA2 -0.5 0.00073 4.46 0 mirMAP -0.58 0 NA
100 hsa-miR-30a-3p HMGA2 -2.26 0 4.46 0 MirTarget -0.51 0 NA
101 hsa-miR-30a-5p HMGA2 -1.8 0 4.46 0 mirMAP -0.62 0 NA
102 hsa-miR-30b-5p HMGA2 -0.4 0.00347 4.46 0 mirMAP -0.39 0.00312 NA
103 hsa-miR-30d-3p HMGA2 -0.58 0 4.46 0 MirTarget -0.58 0.0001 NA
104 hsa-miR-30d-5p HMGA2 -0.38 0.00017 4.46 0 mirMAP -0.92 0 NA
105 hsa-miR-30e-3p HMGA2 -0.89 0 4.46 0 MirTarget -1.38 0 NA
106 hsa-miR-30e-5p HMGA2 -1.02 0 4.46 0 mirMAP -1.28 0 NA
107 hsa-miR-337-3p HMGA2 -1.7 0 4.46 0 MirTarget; PITA -0.22 0.00394 NA
108 hsa-miR-340-5p HMGA2 -0.61 4.0E-5 4.46 0 mirMAP -0.34 0.00498 NA
109 hsa-miR-34a-5p HMGA2 -0.12 0.364 4.46 0 miRNAWalker2 validate -0.56 6.0E-5 18803879 miR-34 targets Notch HMGA2 and Bcl-2 genes involved in the self-renewal and survival of cancer stem cells; Human gastric cancer Kato III cells with miR-34 restoration reduced the expression of target genes Bcl-2 Notch and HMGA2; The mechanism of miR-34-mediated suppression of self-renewal appears to be related to the direct modulation of downstream targets Bcl-2 Notch and HMGA2 indicating that miR-34 may be involved in gastric cancer stem cell self-renewal/differentiation decision-making
110 hsa-miR-381-3p HMGA2 -2.21 0 4.46 0 mirMAP -0.23 0.0037 NA
111 hsa-miR-491-5p HMGA2 -0.54 0.00136 4.46 0 PITA; miRanda -0.33 0.00326 NA
112 hsa-miR-497-5p HMGA2 -0.97 0 4.46 0 MirTarget -0.94 0 NA
113 hsa-miR-532-5p HMGA2 -0.02 0.83099 4.46 0 mirMAP -0.58 0.00111 NA
114 hsa-miR-664a-3p HMGA2 -0.26 0.05132 4.46 0 mirMAP -0.48 0.00049 NA
115 hsa-miR-664a-5p HMGA2 -0.87 0 4.46 0 MirTarget -0.56 0 NA
116 hsa-let-7a-3p LEF1 0.1 0.42376 0.49 0.01109 miRNATAP -0.28 7.0E-5 NA
117 hsa-miR-193b-3p LEF1 1.73 0 0.49 0.01109 miRNAWalker2 validate -0.31 0 NA
118 hsa-miR-455-5p LEF1 1.41 0 0.49 0.01109 miRanda -0.21 0.00012 NA
119 hsa-let-7a-3p LIMS1 0.1 0.42376 0.2 0.25634 mirMAP -0.33 0 NA
120 hsa-miR-140-5p LIMS1 -0.41 0.00014 0.2 0.25634 miRanda -0.2 0.00499 NA
121 hsa-miR-148b-5p LIMS1 1.15 0 0.2 0.25634 MirTarget -0.31 0 NA
122 hsa-miR-182-5p LIMS1 1.15 0 0.2 0.25634 MirTarget; miRNATAP -0.17 2.0E-5 NA
123 hsa-miR-186-5p LIMS1 0.35 0.00015 0.2 0.25634 mirMAP -0.5 0 NA
124 hsa-miR-18a-3p LIMS1 1.83 0 0.2 0.25634 miRNAWalker2 validate -0.15 3.0E-5 NA
125 hsa-miR-193a-3p LIMS1 0.22 0.11183 0.2 0.25634 MirTarget; miRanda -0.16 0.00379 NA
126 hsa-miR-205-3p LIMS1 1.3 0 0.2 0.25634 MirTarget -0.11 0.00249 NA
127 hsa-miR-222-3p LIMS1 1.08 0 0.2 0.25634 MirTarget -0.21 7.0E-5 NA
128 hsa-miR-29b-3p LIMS1 -0.11 0.51126 0.2 0.25634 MirTarget; miRNATAP -0.44 0 NA
129 hsa-miR-30a-5p LIMS1 -1.8 0 0.2 0.25634 MirTarget -0.19 1.0E-5 NA
130 hsa-miR-30b-5p LIMS1 -0.4 0.00347 0.2 0.25634 MirTarget -0.52 0 NA
131 hsa-miR-30c-5p LIMS1 0.02 0.88637 0.2 0.25634 MirTarget -0.53 0 NA
132 hsa-miR-30d-3p LIMS1 -0.58 0 0.2 0.25634 mirMAP -0.42 0 NA
133 hsa-miR-30e-5p LIMS1 -1.02 0 0.2 0.25634 MirTarget -0.26 1.0E-5 NA
134 hsa-miR-3607-3p LIMS1 1.01 9.0E-5 0.2 0.25634 mirMAP -0.2 0 NA
135 hsa-miR-374a-3p LIMS1 -0.3 0.00683 0.2 0.25634 mirMAP -0.31 0 NA
136 hsa-miR-429 LIMS1 0.56 0.00564 0.2 0.25634 miRanda; miRNATAP -0.25 0 NA
137 hsa-miR-505-3p LIMS1 0.91 0 0.2 0.25634 miRNAWalker2 validate; MirTarget -0.29 0 NA
138 hsa-miR-576-5p LIMS1 0.94 0 0.2 0.25634 mirMAP -0.41 0 NA
139 hsa-miR-590-3p LIMS1 0.22 0.09659 0.2 0.25634 miRNAWalker2 validate; miRanda -0.2 0.00035 NA
140 hsa-miR-7-1-3p LIMS1 1.14 0 0.2 0.25634 mirMAP -0.28 0 NA
141 hsa-miR-96-5p LIMS1 1.42 0 0.2 0.25634 TargetScan; miRNATAP -0.19 0 NA
142 hsa-miR-338-3p LOXL2 -0.95 0 3.12 0 miRanda -0.33 0 NA
143 hsa-miR-362-5p LOXL3 0.41 0.04043 1.33 0 TargetScan -0.12 0.00271 NA
144 hsa-miR-148a-3p NOG -0.43 0.00954 -0.81 0.02813 MirTarget; miRNATAP -0.34 0.00046 NA
145 hsa-miR-148b-3p NOG 0.39 0 -0.81 0.02813 MirTarget -0.76 8.0E-5 NA
146 hsa-miR-200b-3p NOG 0.07 0.68286 -0.81 0.02813 MirTarget; TargetScan -0.8 0 NA
147 hsa-miR-200c-3p NOG 0.63 0.00013 -0.81 0.02813 MirTarget; miRNATAP -0.7 0 NA
148 hsa-miR-429 NOG 0.56 0.00564 -0.81 0.02813 MirTarget; PITA; miRanda; miRNATAP -0.54 0 NA
149 hsa-miR-18a-3p NOTCH1 1.83 0 -0.1 0.54477 MirTarget -0.11 0.00052 NA
150 hsa-miR-199b-5p NOTCH1 -1.08 0 -0.1 0.54477 miRanda -0.11 0.00583 24659709 Epigenetic silencing of microRNA 199b 5p is associated with acquired chemoresistance via activation of JAG1 Notch1 signaling in ovarian cancer; Here we report that the loss of miR-199b-5p due to progressive epigenetic silencing leads to the activation of the JAG1-mediated Notch1 signaling cascade thereby leading to the development of acquired chemoresistance in ovarian cancer

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 EPITHELIAL TO MESENCHYMAL TRANSITION 27 56 6.097e-73 2.837e-69
2 MESENCHYMAL CELL DIFFERENTIATION 27 134 1.232e-60 2.866e-57
3 MESENCHYME DEVELOPMENT 27 190 3.662e-56 4.26e-53
4 STEM CELL DIFFERENTIATION 27 190 3.662e-56 4.26e-53
5 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 27 513 5.631e-44 5.24e-41
6 CELLULAR COMPONENT MORPHOGENESIS 27 900 2.974e-37 2.306e-34
7 CELL DEVELOPMENT 27 1426 8.58e-32 5.703e-29
8 TISSUE DEVELOPMENT 27 1518 4.711e-31 2.74e-28
9 TISSUE MORPHOGENESIS 21 533 1.505e-28 7.782e-26
10 RESPONSE TO GROWTH FACTOR 19 475 1.791e-25 8.334e-23
11 MORPHOGENESIS OF AN EPITHELIUM 18 400 7.124e-25 3.013e-22
12 GLAND DEVELOPMENT 17 395 5.294e-23 1.971e-20
13 REGULATION OF STEM CELL DIFFERENTIATION 13 113 5.506e-23 1.971e-20
14 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 21 1021 1.338e-22 4.445e-20
15 ORGAN MORPHOGENESIS 20 841 1.613e-22 5.004e-20
16 REGULATION OF OSSIFICATION 14 178 2.111e-22 6.139e-20
17 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 21 1142 1.385e-21 3.583e-19
18 MESENCHYME MORPHOGENESIS 10 38 1.386e-21 3.583e-19
19 REGULATION OF CARTILAGE DEVELOPMENT 11 63 1.51e-21 3.699e-19
20 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 20 957 2.111e-21 4.911e-19
21 EMBRYONIC ORGAN DEVELOPMENT 16 406 6.594e-21 1.461e-18
22 NEGATIVE REGULATION OF GENE EXPRESSION 22 1493 7.81e-21 1.58e-18
23 REGULATION OF CELL DIFFERENTIATION 22 1492 7.697e-21 1.58e-18
24 EMBRYONIC MORPHOGENESIS 17 539 1.07e-20 2.075e-18
25 REGULATION OF ORGAN MORPHOGENESIS 14 242 1.723e-20 3.208e-18
26 EMBRYO DEVELOPMENT 19 894 2.983e-20 5.143e-18
27 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 10 50 2.984e-20 5.143e-18
28 EPITHELIUM DEVELOPMENT 19 945 8.476e-20 1.36e-17
29 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 20 1152 8.325e-20 1.36e-17
30 REGULATION OF CELLULAR COMPONENT MOVEMENT 18 771 9.857e-20 1.529e-17
31 REGULATION OF EPITHELIAL CELL PROLIFERATION 14 285 1.757e-19 2.638e-17
32 POSITIVE REGULATION OF GENE EXPRESSION 22 1733 1.992e-19 2.896e-17
33 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 19 1008 2.85e-19 4.018e-17
34 POSITIVE REGULATION OF CELL DIFFERENTIATION 18 823 3.159e-19 4.323e-17
35 REGULATION OF CELL DEVELOPMENT 18 836 4.176e-19 5.552e-17
36 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 21 1517 5.028e-19 6.498e-17
37 TUBE DEVELOPMENT 16 552 9.014e-19 1.134e-16
38 TUBE MORPHOGENESIS 14 323 1.029e-18 1.26e-16
39 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 20 1360 2.194e-18 2.617e-16
40 SKELETAL SYSTEM DEVELOPMENT 15 455 2.439e-18 2.837e-16
41 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 21 1672 3.745e-18 4.25e-16
42 NEGATIVE REGULATION OF CELL COMMUNICATION 19 1192 6.574e-18 7.283e-16
43 CONNECTIVE TISSUE DEVELOPMENT 12 194 7.535e-18 7.969e-16
44 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 18 983 7.424e-18 7.969e-16
45 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 17 801 8.613e-18 8.906e-16
46 REGULATION OF CELL DEATH 20 1472 1.037e-17 1.049e-15
47 REGULATION OF STEM CELL PROLIFERATION 10 88 1.273e-17 1.26e-15
48 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 9 53 1.423e-17 1.352e-15
49 REGULATION OF CELL PROLIFERATION 20 1496 1.424e-17 1.352e-15
50 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 21 1805 1.809e-17 1.684e-15
51 HEART MORPHOGENESIS 12 212 2.224e-17 2.029e-15
52 UROGENITAL SYSTEM DEVELOPMENT 13 299 2.388e-17 2.137e-15
53 CARTILAGE DEVELOPMENT 11 147 2.726e-17 2.394e-15
54 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 21 1848 2.935e-17 2.529e-15
55 NEGATIVE REGULATION OF CELL DEATH 17 872 3.574e-17 3.024e-15
56 POSITIVE REGULATION OF LOCOMOTION 14 420 4.094e-17 3.402e-15
57 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 8 34 6.219e-17 5.077e-15
58 LOCOMOTION 18 1114 6.779e-17 5.438e-15
59 MORPHOGENESIS OF A BRANCHING STRUCTURE 11 167 1.145e-16 9.033e-15
60 MESODERM MORPHOGENESIS 9 66 1.176e-16 9.12e-15
61 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 19 1395 1.227e-16 9.362e-15
62 FORMATION OF PRIMARY GERM LAYER 10 110 1.3e-16 9.76e-15
63 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 67 1.357e-16 1.003e-14
64 POSITIVE REGULATION OF CELL DEVELOPMENT 14 472 2.082e-16 1.514e-14
65 RESPONSE TO ENDOGENOUS STIMULUS 19 1450 2.514e-16 1.8e-14
66 SENSORY ORGAN DEVELOPMENT 14 493 3.812e-16 2.687e-14
67 KIDNEY EPITHELIUM DEVELOPMENT 10 125 4.861e-16 3.376e-14
68 CELL MOTILITY 16 835 6.276e-16 4.232e-14
69 LOCALIZATION OF CELL 16 835 6.276e-16 4.232e-14
70 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 18 1275 7.285e-16 4.813e-14
71 REGULATION OF BINDING 12 283 7.344e-16 4.813e-14
72 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 10 131 7.868e-16 5.085e-14
73 CELL PROLIFERATION 15 672 8.055e-16 5.135e-14
74 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 7 24 1.194e-15 7.505e-14
75 REPRODUCTIVE SYSTEM DEVELOPMENT 13 408 1.357e-15 8.421e-14
76 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 14 554 1.918e-15 1.174e-13
77 MESONEPHROS DEVELOPMENT 9 90 2.201e-15 1.33e-13
78 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 7 26 2.264e-15 1.351e-13
79 DIGESTIVE SYSTEM DEVELOPMENT 10 148 2.742e-15 1.615e-13
80 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 10 154 4.111e-15 2.391e-13
81 GLAND MORPHOGENESIS 9 97 4.428e-15 2.513e-13
82 GASTRULATION 10 155 4.391e-15 2.513e-13
83 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 11 236 5.399e-15 3.027e-13
84 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 12 337 5.974e-15 3.306e-13
85 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 14 602 6.039e-15 3.306e-13
86 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 10 162 6.882e-15 3.681e-13
87 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 10 162 6.882e-15 3.681e-13
88 NEGATIVE REGULATION OF CELL DIFFERENTIATION 14 609 7.081e-15 3.744e-13
89 HEART DEVELOPMENT 13 466 7.533e-15 3.939e-13
90 CARDIOVASCULAR SYSTEM DEVELOPMENT 15 788 8.4e-15 4.295e-13
91 CIRCULATORY SYSTEM DEVELOPMENT 15 788 8.4e-15 4.295e-13
92 REGULATION OF CELL ADHESION 14 629 1.105e-14 5.587e-13
93 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 16 1004 1.121e-14 5.606e-13
94 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 19 1784 1.151e-14 5.695e-13
95 POSITIVE REGULATION OF CELL PROLIFERATION 15 814 1.352e-14 6.623e-13
96 NEGATIVE REGULATION OF CELL PROLIFERATION 14 643 1.495e-14 7.247e-13
97 EPITHELIAL CELL DIFFERENTIATION 13 495 1.636e-14 7.848e-13
98 REGULATION OF OSTEOBLAST DIFFERENTIATION 9 112 1.682e-14 7.985e-13
99 MESODERM DEVELOPMENT 9 118 2.723e-14 1.28e-12
100 EMBRYONIC ORGAN MORPHOGENESIS 11 279 3.421e-14 1.592e-12
101 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 10 197 4.984e-14 2.296e-12
102 GROWTH 12 410 6.184e-14 2.821e-12
103 PATTERN SPECIFICATION PROCESS 12 418 7.778e-14 3.514e-12
104 NEUROGENESIS 17 1402 9.338e-14 4.178e-12
105 REGULATION OF WNT SIGNALING PATHWAY 11 310 1.087e-13 4.817e-12
106 IN UTERO EMBRYONIC DEVELOPMENT 11 311 1.126e-13 4.943e-12
107 POSITIVE REGULATION OF OSSIFICATION 8 84 1.431e-13 6.225e-12
108 PALATE DEVELOPMENT 8 85 1.579e-13 6.802e-12
109 REGULATION OF CELLULAR COMPONENT BIOGENESIS 14 767 1.672e-13 7.137e-12
110 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 9 144 1.695e-13 7.171e-12
111 CELL FATE COMMITMENT 10 227 2.073e-13 8.689e-12
112 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 10 229 2.263e-13 9.403e-12
113 ENDOCARDIAL CUSHION MORPHOGENESIS 6 22 2.451e-13 1.009e-11
114 DIGESTIVE TRACT MORPHOGENESIS 7 48 2.486e-13 1.015e-11
115 OSSIFICATION 10 251 5.667e-13 2.293e-11
116 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 8 104 8.315e-13 3.335e-11
117 POSITIVE REGULATION OF RESPONSE TO STIMULUS 18 1929 9.688e-13 3.82e-11
118 AXIS ELONGATION 6 27 9.68e-13 3.82e-11
119 NEURON DIFFERENTIATION 14 874 9.87e-13 3.859e-11
120 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 8 111 1.417e-12 5.494e-11
121 POSITIVE REGULATION OF STEM CELL PROLIFERATION 7 61 1.456e-12 5.601e-11
122 REGULATION OF HEART MORPHOGENESIS 6 29 1.551e-12 5.914e-11
123 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 8 115 1.892e-12 7.099e-11
124 NEPHRON DEVELOPMENT 8 115 1.892e-12 7.099e-11
125 REGULATION OF CELL MORPHOGENESIS 12 552 2.069e-12 7.702e-11
126 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 13 740 2.728e-12 1.007e-10
127 ENDOCARDIAL CUSHION DEVELOPMENT 6 32 2.95e-12 1.081e-10
128 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 5 13 3.87e-12 1.407e-10
129 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 9 207 4.566e-12 1.647e-10
130 REGIONALIZATION 10 311 4.778e-12 1.71e-10
131 REGULATION OF REPRODUCTIVE PROCESS 8 129 4.817e-12 1.711e-10
132 POSITIVE REGULATION OF CELL DEATH 12 605 6.052e-12 2.133e-10
133 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 8 134 6.557e-12 2.294e-10
134 POSITIVE REGULATION OF CELL COMMUNICATION 16 1532 7.549e-12 2.621e-10
135 RENAL TUBULE DEVELOPMENT 7 78 8.689e-12 2.995e-10
136 DEVELOPMENTAL GROWTH 10 333 9.394e-12 3.214e-10
137 REGULATION OF GROWTH 12 633 1.026e-11 3.484e-10
138 REPRODUCTION 15 1297 1.156e-11 3.898e-10
139 PROSTATE GLAND DEVELOPMENT 6 41 1.452e-11 4.86e-10
140 FOREBRAIN DEVELOPMENT 10 357 1.866e-11 6.202e-10
141 REGULATION OF APOPTOTIC SIGNALING PATHWAY 10 363 2.199e-11 7.256e-10
142 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 16 1656 2.462e-11 8.066e-10
143 RESPONSE TO LIPID 13 888 2.689e-11 8.75e-10
144 NEPHRON EPITHELIUM DEVELOPMENT 7 93 3.075e-11 9.937e-10
145 CANONICAL WNT SIGNALING PATHWAY 7 95 3.581e-11 1.149e-09
146 HEAD DEVELOPMENT 12 709 3.832e-11 1.221e-09
147 REGULATION OF PROTEIN BINDING 8 168 4.063e-11 1.286e-09
148 APPENDAGE DEVELOPMENT 8 169 4.261e-11 1.331e-09
149 LIMB DEVELOPMENT 8 169 4.261e-11 1.331e-09
150 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 7 100 5.164e-11 1.602e-09
151 REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 103 6.375e-11 1.952e-09
152 REGULATION OF MUSCLE ORGAN DEVELOPMENT 7 103 6.375e-11 1.952e-09
153 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 10 406 6.6e-11 2.007e-09
154 MESONEPHRIC TUBULE MORPHOGENESIS 6 53 7.334e-11 2.216e-09
155 REGULATION OF KIDNEY DEVELOPMENT 6 55 9.244e-11 2.775e-09
156 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 8 190 1.089e-10 3.247e-09
157 MUSCLE STRUCTURE DEVELOPMENT 10 432 1.211e-10 3.589e-09
158 ANTERIOR POSTERIOR PATTERN SPECIFICATION 8 194 1.286e-10 3.786e-09
159 NEGATIVE REGULATION OF CELL DEVELOPMENT 9 303 1.378e-10 4.032e-09
160 RESPIRATORY SYSTEM DEVELOPMENT 8 197 1.453e-10 4.226e-09
161 STEM CELL PROLIFERATION 6 60 1.589e-10 4.481e-09
162 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 25 1.58e-10 4.481e-09
163 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 6 60 1.589e-10 4.481e-09
164 MAMMARY GLAND DEVELOPMENT 7 117 1.576e-10 4.481e-09
165 RESPONSE TO ABIOTIC STIMULUS 13 1024 1.582e-10 4.481e-09
166 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 8 200 1.639e-10 4.595e-09
167 SKELETAL SYSTEM MORPHOGENESIS 8 201 1.706e-10 4.753e-09
168 RESPONSE TO OXYGEN LEVELS 9 311 1.736e-10 4.808e-09
169 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 13 1036 1.827e-10 5.001e-09
170 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 13 1036 1.827e-10 5.001e-09
171 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 7 121 2e-10 5.441e-09
172 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 7 122 2.12e-10 5.734e-09
173 ENDOCRINE SYSTEM DEVELOPMENT 7 123 2.246e-10 6.04e-09
174 SKIN DEVELOPMENT 8 211 2.511e-10 6.716e-09
175 EYE DEVELOPMENT 9 326 2.635e-10 7.005e-09
176 POSITIVE REGULATION OF BINDING 7 127 2.815e-10 7.443e-09
177 TUBE FORMATION 7 129 3.143e-10 8.263e-09
178 EPIDERMIS MORPHOGENESIS 5 29 3.519e-10 9.198e-09
179 CENTRAL NERVOUS SYSTEM DEVELOPMENT 12 872 4.157e-10 1.081e-08
180 SKIN EPIDERMIS DEVELOPMENT 6 71 4.501e-10 1.157e-08
181 ENDODERM DEVELOPMENT 6 71 4.501e-10 1.157e-08
182 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 13 1135 5.631e-10 1.44e-08
183 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 11 689 5.908e-10 1.502e-08
184 REGULATION OF ORGAN FORMATION 5 32 5.95e-10 1.505e-08
185 REGULATION OF CELLULAR RESPONSE TO STRESS 11 691 6.092e-10 1.532e-08
186 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 6 75 6.306e-10 1.577e-08
187 SENSORY ORGAN MORPHOGENESIS 8 239 6.751e-10 1.68e-08
188 BLOOD VESSEL MORPHOGENESIS 9 364 6.969e-10 1.725e-08
189 REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 34 8.207e-10 2.02e-08
190 POSITIVE REGULATION OF CELL ADHESION 9 376 9.27e-10 2.27e-08
191 REGULATION OF CELL CELL ADHESION 9 380 1.017e-09 2.478e-08
192 PROTEIN PHOSPHORYLATION 12 944 1.029e-09 2.493e-08
193 AMEBOIDAL TYPE CELL MIGRATION 7 154 1.092e-09 2.607e-08
194 REGULATION OF CELL CYCLE 12 949 1.092e-09 2.607e-08
195 KIDNEY MORPHOGENESIS 6 82 1.09e-09 2.607e-08
196 POSITIVE REGULATION OF MOLECULAR FUNCTION 15 1791 1.11e-09 2.635e-08
197 HAIR CYCLE 6 83 1.174e-09 2.758e-08
198 MOLTING CYCLE 6 83 1.174e-09 2.758e-08
199 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 8 262 1.395e-09 3.256e-08
200 RESPONSE TO EXTERNAL STIMULUS 15 1821 1.4e-09 3.256e-08
201 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 11 750 1.444e-09 3.343e-08
202 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 5 39 1.69e-09 3.894e-08
203 REGULATION OF EPITHELIAL CELL MIGRATION 7 166 1.846e-09 4.23e-08
204 MESENCHYMAL CELL PROLIFERATION 4 13 1.867e-09 4.259e-08
205 IMMUNE SYSTEM DEVELOPMENT 10 582 2.178e-09 4.943e-08
206 ANGIOGENESIS 8 293 3.363e-09 7.596e-08
207 EXOCRINE SYSTEM DEVELOPMENT 5 45 3.567e-09 7.981e-08
208 REGULATION OF PHOSPHORUS METABOLIC PROCESS 14 1618 3.568e-09 7.981e-08
209 CAMERA TYPE EYE MORPHOGENESIS 6 101 3.877e-09 8.631e-08
210 REGULATION OF CHONDROCYTE DIFFERENTIATION 5 46 3.999e-09 8.86e-08
211 EPITHELIAL CELL DEVELOPMENT 7 186 4.077e-09 8.992e-08
212 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 6 102 4.115e-09 9.033e-08
213 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 6 103 4.366e-09 9.538e-08
214 CARDIAC CHAMBER MORPHOGENESIS 6 104 4.629e-09 1.007e-07
215 PARAXIAL MESODERM DEVELOPMENT 4 16 4.74e-09 1.021e-07
216 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 4 16 4.74e-09 1.021e-07
217 ODONTOGENESIS 6 105 4.905e-09 1.052e-07
218 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 5 48 4.986e-09 1.059e-07
219 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 5 48 4.986e-09 1.059e-07
220 CARDIAC VENTRICLE DEVELOPMENT 6 106 5.195e-09 1.099e-07
221 EAR DEVELOPMENT 7 195 5.661e-09 1.192e-07
222 BRANCH ELONGATION OF AN EPITHELIUM 4 17 6.193e-09 1.281e-07
223 NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 4 17 6.193e-09 1.281e-07
224 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 4 17 6.193e-09 1.281e-07
225 FACE DEVELOPMENT 5 50 6.158e-09 1.281e-07
226 VASCULATURE DEVELOPMENT 9 469 6.398e-09 1.317e-07
227 REGULATION OF MAPK CASCADE 10 660 7.267e-09 1.487e-07
228 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 11 876 7.32e-09 1.487e-07
229 REGULATION OF PROTEIN MODIFICATION PROCESS 14 1710 7.308e-09 1.487e-07
230 NOTOCHORD DEVELOPMENT 4 18 7.955e-09 1.609e-07
231 NOTCH SIGNALING PATHWAY 6 114 8.063e-09 1.617e-07
232 REGULATION OF EMBRYONIC DEVELOPMENT 6 114 8.063e-09 1.617e-07
233 MAMMARY GLAND EPITHELIUM DEVELOPMENT 5 53 8.317e-09 1.661e-07
234 CARDIAC MUSCLE TISSUE MORPHOGENESIS 5 54 9.158e-09 1.821e-07
235 RESPONSE TO STEROID HORMONE 9 497 1.058e-08 2.095e-07
236 RESPONSE TO ORGANIC CYCLIC COMPOUND 11 917 1.177e-08 2.32e-07
237 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 7 218 1.225e-08 2.405e-07
238 REGULATION OF ORGANELLE ORGANIZATION 12 1178 1.255e-08 2.448e-07
239 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 4 20 1.257e-08 2.448e-07
240 REGULATION OF RESPONSE TO STRESS 13 1468 1.289e-08 2.499e-07
241 EMBRYONIC PATTERN SPECIFICATION 5 58 1.322e-08 2.552e-07
242 OSTEOBLAST DIFFERENTIATION 6 126 1.473e-08 2.832e-07
243 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 13 1492 1.567e-08 2.999e-07
244 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 5 60 1.573e-08 2.999e-07
245 HEPATICOBILIARY SYSTEM DEVELOPMENT 6 128 1.619e-08 3.075e-07
246 REGULATION OF PROTEIN LOCALIZATION 11 950 1.697e-08 3.209e-07
247 SOMATIC STEM CELL DIVISION 4 22 1.895e-08 3.569e-07
248 POSITIVE REGULATION OF CATALYTIC ACTIVITY 13 1518 1.928e-08 3.617e-07
249 REGULATION OF VASCULATURE DEVELOPMENT 7 233 1.938e-08 3.622e-07
250 PHOSPHORYLATION 12 1228 1.998e-08 3.718e-07
251 NEUROEPITHELIAL CELL DIFFERENTIATION 5 63 2.019e-08 3.742e-07
252 MUSCLE CELL DIFFERENTIATION 7 237 2.179e-08 4.024e-07
253 PROSTATE GLAND MORPHOGENESIS 4 23 2.291e-08 4.214e-07
254 EYE MORPHOGENESIS 6 136 2.329e-08 4.267e-07
255 REGULATION OF CELLULAR PROTEIN LOCALIZATION 9 552 2.62e-08 4.78e-07
256 NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 4 24 2.747e-08 4.993e-07
257 CARDIAC MUSCLE TISSUE DEVELOPMENT 6 140 2.771e-08 5.016e-07
258 REGULATION OF CELL JUNCTION ASSEMBLY 5 68 2.98e-08 5.354e-07
259 ORGAN GROWTH 5 68 2.98e-08 5.354e-07
260 REGULATION OF CYTOKINE PRODUCTION 9 563 3.104e-08 5.556e-07
261 NEGATIVE REGULATION OF OSSIFICATION 5 69 3.21e-08 5.722e-07
262 CARDIAC CHAMBER DEVELOPMENT 6 144 3.279e-08 5.801e-07
263 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 4 25 3.267e-08 5.801e-07
264 EPIDERMIS DEVELOPMENT 7 253 3.414e-08 6.017e-07
265 MUSCLE ORGAN MORPHOGENESIS 5 70 3.454e-08 6.064e-07
266 RESPONSE TO ESTRADIOL 6 146 3.561e-08 6.228e-07
267 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 9 573 3.612e-08 6.294e-07
268 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 4 26 3.858e-08 6.698e-07
269 EMBRYONIC HEART TUBE DEVELOPMENT 5 73 4.274e-08 7.366e-07
270 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 5 73 4.274e-08 7.366e-07
271 NEGATIVE REGULATION OF LOCOMOTION 7 263 4.453e-08 7.646e-07
272 DEVELOPMENTAL INDUCTION 4 27 4.525e-08 7.69e-07
273 REGULATION OF MUSCLE CELL DIFFERENTIATION 6 152 4.528e-08 7.69e-07
274 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 4.525e-08 7.69e-07
275 VENTRICULAR SEPTUM MORPHOGENESIS 4 28 5.274e-08 8.859e-07
276 REGULATION OF NEUROBLAST PROLIFERATION 4 28 5.274e-08 8.859e-07
277 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 5.274e-08 8.859e-07
278 DIENCEPHALON DEVELOPMENT 5 77 5.602e-08 9.376e-07
279 SOMITE DEVELOPMENT 5 78 5.98e-08 9.973e-07
280 MUSCLE TISSUE DEVELOPMENT 7 275 6.043e-08 1.004e-06
281 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 4 29 6.112e-08 1.005e-06
282 STEM CELL DIVISION 4 29 6.112e-08 1.005e-06
283 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 4 29 6.112e-08 1.005e-06
284 SMOOTH MUSCLE CELL DIFFERENTIATION 4 30 7.046e-08 1.154e-06
285 RESPONSE TO OXYGEN CONTAINING COMPOUND 12 1381 7.352e-08 1.2e-06
286 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 8 437 7.516e-08 1.223e-06
287 ORGAN REGENERATION 5 83 8.187e-08 1.323e-06
288 EMBRYONIC PLACENTA DEVELOPMENT 5 83 8.187e-08 1.323e-06
289 SALIVARY GLAND DEVELOPMENT 4 32 9.228e-08 1.486e-06
290 GLIOGENESIS 6 175 1.047e-07 1.679e-06
291 CELLULAR RESPONSE TO LIPID 8 457 1.06e-07 1.695e-06
292 HEART VALVE DEVELOPMENT 4 34 1.188e-07 1.893e-06
293 RESPONSE TO HORMONE 10 893 1.263e-07 2.006e-06
294 POSITIVE REGULATION OF MAPK CASCADE 8 470 1.314e-07 2.08e-06
295 REGULATION OF PROTEIN IMPORT 6 183 1.364e-07 2.151e-06
296 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 5 93 1.452e-07 2.279e-06
297 CELL JUNCTION ORGANIZATION 6 185 1.455e-07 2.279e-06
298 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 4 36 1.506e-07 2.336e-06
299 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 4 36 1.506e-07 2.336e-06
300 HEAD MORPHOGENESIS 4 36 1.506e-07 2.336e-06
301 RESPONSE TO BMP 5 94 1.532e-07 2.361e-06
302 CELLULAR RESPONSE TO BMP STIMULUS 5 94 1.532e-07 2.361e-06
303 REGULATION OF MAP KINASE ACTIVITY 7 319 1.66e-07 2.55e-06
304 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 4 37 1.687e-07 2.574e-06
305 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 4 37 1.687e-07 2.574e-06
306 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 4 38 1.884e-07 2.865e-06
307 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 4 39 2.097e-07 3.179e-06
308 REGULATION OF TRANSFERASE ACTIVITY 10 946 2.161e-07 3.265e-06
309 POSITIVE REGULATION OF CELL CYCLE 7 332 2.177e-07 3.278e-06
310 MAMMARY GLAND MORPHOGENESIS 4 40 2.328e-07 3.483e-06
311 POSITIVE REGULATION OF CELL MATRIX ADHESION 4 40 2.328e-07 3.483e-06
312 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 4 41 2.577e-07 3.844e-06
313 PITUITARY GLAND DEVELOPMENT 4 42 2.846e-07 4.231e-06
314 WNT SIGNALING PATHWAY 7 351 3.171e-07 4.699e-06
315 BODY MORPHOGENESIS 4 44 3.445e-07 5.057e-06
316 NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 4 44 3.445e-07 5.057e-06
317 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 4 44 3.445e-07 5.057e-06
318 REGULATION OF CELLULAR LOCALIZATION 11 1277 3.468e-07 5.075e-06
319 REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 3 11 3.594e-07 5.21e-06
320 EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 3 11 3.594e-07 5.21e-06
321 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 3 11 3.594e-07 5.21e-06
322 LUNG MORPHOGENESIS 4 45 3.778e-07 5.443e-06
323 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 4 45 3.778e-07 5.443e-06
324 RESPONSE TO ESTROGEN 6 218 3.827e-07 5.497e-06
325 RESPONSE TO ALCOHOL 7 362 3.904e-07 5.59e-06
326 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 6 220 4.038e-07 5.764e-06
327 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 7 368 4.362e-07 6.184e-06
328 NEGATIVE REGULATION OF CELL ADHESION 6 223 4.372e-07 6.184e-06
329 MULTICELLULAR ORGANISM REPRODUCTION 9 768 4.357e-07 6.184e-06
330 REGULATION OF NEURON DIFFERENTIATION 8 554 4.597e-07 6.482e-06
331 REGULATION OF KINASE ACTIVITY 9 776 4.753e-07 6.682e-06
332 REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 3 12 4.788e-07 6.69e-06
333 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 3 12 4.788e-07 6.69e-06
334 REGULATION OF CELL CYCLE PROCESS 8 558 4.854e-07 6.763e-06
335 TELENCEPHALON DEVELOPMENT 6 228 4.979e-07 6.916e-06
336 REGULATION OF STEROID BIOSYNTHETIC PROCESS 4 49 5.353e-07 7.391e-06
337 CARDIAC SEPTUM MORPHOGENESIS 4 49 5.353e-07 7.391e-06
338 NEGATIVE REGULATION OF GROWTH 6 236 6.094e-07 8.389e-06
339 POSITIVE REGULATION OF GROWTH 6 238 6.402e-07 8.787e-06
340 REGULATION OF CELL GROWTH 7 391 6.555e-07 8.971e-06
341 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 4 52 6.821e-07 9.307e-06
342 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 4 54 7.953e-07 1.066e-05
343 CELL MIGRATION INVOLVED IN GASTRULATION 3 14 7.908e-07 1.066e-05
344 NEURON PROJECTION MORPHOGENESIS 7 402 7.895e-07 1.066e-05
345 EMBRYONIC SKELETAL JOINT DEVELOPMENT 3 14 7.908e-07 1.066e-05
346 VENTRICULAR SEPTUM DEVELOPMENT 4 54 7.953e-07 1.066e-05
347 CONVERGENT EXTENSION 3 14 7.908e-07 1.066e-05
348 NEGATIVE REGULATION OF BINDING 5 131 8.029e-07 1.074e-05
349 POSITIVE REGULATION OF CELL DIVISION 5 132 8.338e-07 1.112e-05
350 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 4 55 8.569e-07 1.136e-05
351 CRANIAL SKELETAL SYSTEM DEVELOPMENT 4 55 8.569e-07 1.136e-05
352 SMAD PROTEIN SIGNAL TRANSDUCTION 4 56 9.22e-07 1.212e-05
353 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 4 56 9.22e-07 1.212e-05
354 OUTFLOW TRACT MORPHOGENESIS 4 56 9.22e-07 1.212e-05
355 CELL GROWTH 5 135 9.32e-07 1.222e-05
356 GLIAL CELL DIFFERENTIATION 5 136 9.666e-07 1.263e-05
357 ENDOCARDIAL CUSHION FORMATION 3 15 9.876e-07 1.276e-05
358 MORPHOGENESIS OF AN EPITHELIAL FOLD 3 15 9.876e-07 1.276e-05
359 REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 3 15 9.876e-07 1.276e-05
360 STRIATED MUSCLE CELL PROLIFERATION 3 15 9.876e-07 1.276e-05
361 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 8 616 1.023e-06 1.319e-05
362 NEGATIVE REGULATION OF CELL CELL ADHESION 5 138 1.039e-06 1.332e-05
363 PLACENTA DEVELOPMENT 5 138 1.039e-06 1.332e-05
364 NON CANONICAL WNT SIGNALING PATHWAY 5 140 1.116e-06 1.426e-05
365 REGULATION OF GLIAL CELL DIFFERENTIATION 4 59 1.139e-06 1.452e-05
366 CHONDROCYTE DIFFERENTIATION 4 60 1.22e-06 1.55e-05
367 SEX DIFFERENTIATION 6 266 1.225e-06 1.553e-05
368 NEGATIVE REGULATION OF CELL CYCLE 7 433 1.297e-06 1.64e-05
369 EMBRYONIC DIGIT MORPHOGENESIS 4 61 1.304e-06 1.644e-05
370 CARDIAC VENTRICLE MORPHOGENESIS 4 62 1.393e-06 1.749e-05
371 REGULATION OF CELL DIVISION 6 272 1.394e-06 1.749e-05
372 MALE SEX DIFFERENTIATION 5 148 1.468e-06 1.836e-05
373 POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 3 17 1.473e-06 1.838e-05
374 ACTIVATION OF PROTEIN KINASE ACTIVITY 6 279 1.616e-06 2.01e-05
375 REGULATION OF HORMONE BIOSYNTHETIC PROCESS 3 18 1.766e-06 2.18e-05
376 PERICARDIUM DEVELOPMENT 3 18 1.766e-06 2.18e-05
377 NEPHRON TUBULE FORMATION 3 18 1.766e-06 2.18e-05
378 LENS DEVELOPMENT IN CAMERA TYPE EYE 4 66 1.793e-06 2.207e-05
379 PROTEIN LOCALIZATION TO NUCLEUS 5 156 1.903e-06 2.336e-05
380 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 68 2.022e-06 2.476e-05
381 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 7 465 2.083e-06 2.544e-05
382 MUSCLE CELL PROLIFERATION 3 19 2.096e-06 2.553e-05
383 REGENERATION 5 161 2.222e-06 2.7e-05
384 WOUND HEALING 7 470 2.236e-06 2.703e-05
385 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 7 470 2.236e-06 2.703e-05
386 TRACHEA DEVELOPMENT 3 20 2.463e-06 2.962e-05
387 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 3 20 2.463e-06 2.962e-05
388 POSITIVE REGULATION OF KINASE ACTIVITY 7 482 2.643e-06 3.169e-05
389 EXTRACELLULAR STRUCTURE ORGANIZATION 6 304 2.655e-06 3.176e-05
390 POSITIVE REGULATION OF PROTEIN BINDING 4 73 2.69e-06 3.209e-05
391 REGULATION OF PROTEIN TARGETING 6 307 2.81e-06 3.344e-05
392 REGULATION OF STEROID METABOLIC PROCESS 4 74 2.841e-06 3.372e-05
393 POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 3 21 2.871e-06 3.382e-05
394 LEFT RIGHT PATTERN FORMATION 3 21 2.871e-06 3.382e-05
395 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 3 21 2.871e-06 3.382e-05
396 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 4 75 2.998e-06 3.514e-05
397 NEURAL CREST CELL DIFFERENTIATION 4 75 2.998e-06 3.514e-05
398 REGULATION OF CELL SUBSTRATE ADHESION 5 173 3.162e-06 3.697e-05
399 EMBRYONIC PLACENTA MORPHOGENESIS 3 22 3.322e-06 3.864e-05
400 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 3 22 3.322e-06 3.864e-05
401 RESPONSE TO ACID CHEMICAL 6 319 3.506e-06 4.068e-05
402 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 12 1977 3.546e-06 4.104e-05
403 IMMUNE SYSTEM PROCESS 12 1984 3.68e-06 4.249e-05
404 NEGATIVE REGULATION OF PROTEIN BINDING 4 79 3.693e-06 4.253e-05
405 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 4 80 3.883e-06 4.45e-05
406 CELLULAR RESPONSE TO MECHANICAL STIMULUS 4 80 3.883e-06 4.45e-05
407 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 7 514 4.039e-06 4.618e-05
408 METANEPHROS DEVELOPMENT 4 81 4.081e-06 4.654e-05
409 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 3 24 4.358e-06 4.933e-05
410 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 3 24 4.358e-06 4.933e-05
411 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 3 24 4.358e-06 4.933e-05
412 POSITIVE REGULATION OF DNA METABOLIC PROCESS 5 185 4.39e-06 4.958e-05
413 RESPONSE TO METAL ION 6 333 4.488e-06 5.056e-05
414 REGULATION OF HYDROLASE ACTIVITY 10 1327 4.75e-06 5.339e-05
415 CARDIAC SEPTUM DEVELOPMENT 4 85 4.949e-06 5.509e-05
416 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 3 25 4.947e-06 5.509e-05
417 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 25 4.947e-06 5.509e-05
418 POSITIVE REGULATION OF CHROMATIN MODIFICATION 4 85 4.949e-06 5.509e-05
419 REGULATION OF DNA METABOLIC PROCESS 6 340 5.057e-06 5.616e-05
420 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 5 191 5.13e-06 5.684e-05
421 CELL CELL SIGNALING 8 767 5.236e-06 5.787e-05
422 TISSUE REMODELING 4 87 5.43e-06 5.987e-05
423 NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION 3 26 5.588e-06 6.103e-05
424 REGULATION OF MESONEPHROS DEVELOPMENT 3 26 5.588e-06 6.103e-05
425 HEART GROWTH 3 26 5.588e-06 6.103e-05
426 REGULATION OF HORMONE METABOLIC PROCESS 3 26 5.588e-06 6.103e-05
427 NEURON PROJECTION DEVELOPMENT 7 545 5.934e-06 6.464e-05
428 EPITHELIAL CELL PROLIFERATION 4 89 5.946e-06 6.464e-05
429 AXIS SPECIFICATION 4 90 6.216e-06 6.711e-05
430 REGULATION OF CELL MATRIX ADHESION 4 90 6.216e-06 6.711e-05
431 REGULATION OF GLIOGENESIS 4 90 6.216e-06 6.711e-05
432 REGULATION OF ASTROCYTE DIFFERENTIATION 3 27 6.28e-06 6.733e-05
433 RESPONSE TO LITHIUM ION 3 27 6.28e-06 6.733e-05
434 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 3 27 6.28e-06 6.733e-05
435 DOPAMINERGIC NEURON DIFFERENTIATION 3 28 7.028e-06 7.5e-05
436 METANEPHROS MORPHOGENESIS 3 28 7.028e-06 7.5e-05
437 REGULATION OF DNA BINDING 4 93 7.084e-06 7.542e-05
438 NEGATIVE REGULATION OF MOLECULAR FUNCTION 9 1079 7.257e-06 7.709e-05
439 RESPONSE TO WOUNDING 7 563 7.341e-06 7.781e-05
440 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 4 95 7.709e-06 8.153e-05
441 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 3 29 7.832e-06 8.245e-05
442 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 3 29 7.832e-06 8.245e-05
443 POSITIVE REGULATION OF CYTOKINE PRODUCTION 6 370 8.203e-06 8.616e-05
444 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 5 211 8.329e-06 8.728e-05
445 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 98 8.724e-06 9.121e-05
446 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 4 99 9.082e-06 9.476e-05
447 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 4 100 9.452e-06 9.839e-05
448 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 6 381 9.693e-06 0.0001007
449 REGULATION OF TRANSPORT 11 1804 1.04e-05 0.0001078
450 PROTEIN LOCALIZATION 11 1805 1.046e-05 0.0001081
451 EMBRYONIC AXIS SPECIFICATION 3 33 1.165e-05 0.0001194
452 REGULATION OF T CELL APOPTOTIC PROCESS 3 33 1.165e-05 0.0001194
453 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 3 33 1.165e-05 0.0001194
454 EMBRYONIC EYE MORPHOGENESIS 3 33 1.165e-05 0.0001194
455 REGULATION OF FAT CELL DIFFERENTIATION 4 106 1.191e-05 0.0001218
456 ORGAN FORMATION 3 34 1.277e-05 0.0001303
457 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 7 616 1.319e-05 0.0001343
458 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 6 404 1.352e-05 0.0001374
459 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 3 35 1.395e-05 0.0001414
460 EAR MORPHOGENESIS 4 112 1.481e-05 0.0001498
461 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 3 36 1.521e-05 0.0001535
462 MULTI ORGANISM REPRODUCTIVE PROCESS 8 891 1.567e-05 0.0001578
463 CELL PART MORPHOGENESIS 7 633 1.573e-05 0.0001581
464 PROTEIN COMPLEX SUBUNIT ORGANIZATION 10 1527 1.649e-05 0.0001654
465 NEGATIVE REGULATION OF GLIOGENESIS 3 37 1.653e-05 0.0001654
466 RESPONSE TO FIBROBLAST GROWTH FACTOR 4 116 1.701e-05 0.0001698
467 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 4 117 1.759e-05 0.0001749
468 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 4 117 1.759e-05 0.0001749
469 POSITIVE REGULATION OF CELL CYCLE PROCESS 5 247 1.784e-05 0.000177
470 COLLAGEN FIBRIL ORGANIZATION 3 38 1.794e-05 0.0001772
471 BONE MINERALIZATION 3 38 1.794e-05 0.0001772
472 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 4 118 1.819e-05 0.0001794
473 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 4 121 2.009e-05 0.0001976
474 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 4 122 2.075e-05 0.0002037
475 LEUKOCYTE CELL CELL ADHESION 5 255 2.079e-05 0.0002037
476 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 6 437 2.108e-05 0.0002061
477 CELLULAR MACROMOLECULE LOCALIZATION 9 1234 2.139e-05 0.0002086
478 T CELL DIFFERENTIATION 4 123 2.143e-05 0.0002086
479 CELLULAR RESPONSE TO ABIOTIC STIMULUS 5 263 2.411e-05 0.0002342
480 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 3 42 2.432e-05 0.0002343
481 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 3 42 2.432e-05 0.0002343
482 REGULATION OF HEART GROWTH 3 42 2.432e-05 0.0002343
483 GENITALIA DEVELOPMENT 3 42 2.432e-05 0.0002343
484 CELLULAR RESPONSE TO EXTERNAL STIMULUS 5 264 2.456e-05 0.0002356
485 AGING 5 264 2.456e-05 0.0002356
486 REGULATION OF LIPID BIOSYNTHETIC PROCESS 4 128 2.506e-05 0.0002399
487 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 4 129 2.584e-05 0.0002469
488 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 7 684 2.592e-05 0.0002471
489 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 3 43 2.612e-05 0.0002485
490 NEURON DEVELOPMENT 7 687 2.666e-05 0.0002531
491 SINGLE ORGANISM CELL ADHESION 6 459 2.779e-05 0.0002634
492 MAINTENANCE OF CELL NUMBER 4 132 2.828e-05 0.0002675
493 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 5 274 2.934e-05 0.000277
494 TAXIS 6 464 2.953e-05 0.0002782
495 SPROUTING ANGIOGENESIS 3 45 2.998e-05 0.0002812
496 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 3 45 2.998e-05 0.0002812
497 MUSCLE ORGAN DEVELOPMENT 5 277 3.091e-05 0.0002888
498 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 4 135 3.089e-05 0.0002888
499 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 3 46 3.204e-05 0.0002988
500 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 4 138 3.366e-05 0.0003127
501 REGULATION OF LIPID METABOLIC PROCESS 5 282 3.367e-05 0.0003127
502 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 3 47 3.42e-05 0.000317
503 RESPONSE TO INORGANIC SUBSTANCE 6 479 3.53e-05 0.0003265
504 REGULATION OF CYTOPLASMIC TRANSPORT 6 481 3.613e-05 0.0003335
505 CELL DEATH 8 1001 3.625e-05 0.000334
506 REGULATION OF MYOBLAST DIFFERENTIATION 3 48 3.644e-05 0.0003345
507 ANTERIOR POSTERIOR AXIS SPECIFICATION 3 48 3.644e-05 0.0003345
508 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 7 724 3.729e-05 0.0003415
509 REGULATION OF DEVELOPMENTAL GROWTH 5 289 3.785e-05 0.000346
510 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 4 143 3.87e-05 0.0003531
511 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 4 145 4.086e-05 0.000372
512 REGULATION OF ADHERENS JUNCTION ORGANIZATION 3 50 4.122e-05 0.0003739
513 ENDODERM FORMATION 3 50 4.122e-05 0.0003739
514 ARTERY MORPHOGENESIS 3 51 4.376e-05 0.0003961
515 POSITIVE REGULATION OF CELL GROWTH 4 148 4.426e-05 0.0003999
516 BIOLOGICAL ADHESION 8 1032 4.507e-05 0.0004064
517 NEURAL TUBE DEVELOPMENT 4 149 4.544e-05 0.0004089
518 NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 3 52 4.64e-05 0.0004168
519 POSITIVE REGULATION OF CHROMOSOME ORGANIZATION 4 150 4.664e-05 0.0004181
520 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 5 303 4.741e-05 0.0004243
521 REGULATION OF CHROMATIN ORGANIZATION 4 152 4.911e-05 0.0004378
522 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 4 152 4.911e-05 0.0004378
523 POSITIVE REGULATION OF NEURON DIFFERENTIATION 5 306 4.969e-05 0.0004421
524 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 4 153 5.039e-05 0.0004466
525 PALLIUM DEVELOPMENT 4 153 5.039e-05 0.0004466
526 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 3 54 5.198e-05 0.0004598
527 BONE DEVELOPMENT 4 156 5.435e-05 0.0004789
528 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 4 156 5.435e-05 0.0004789
529 REGULATION OF HEMOPOIESIS 5 314 5.616e-05 0.000494
530 POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 3 57 6.115e-05 0.0005359
531 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 57 6.115e-05 0.0005359
532 REGULATION OF NUCLEAR DIVISION 4 163 6.447e-05 0.0005628
533 CELLULAR RESPONSE TO BIOTIC STIMULUS 4 163 6.447e-05 0.0005628
534 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 8 1087 6.516e-05 0.0005678
535 POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 3 59 6.782e-05 0.0005899
536 CHROMATIN MODIFICATION 6 539 6.808e-05 0.000591
537 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 6 541 6.949e-05 0.000601
538 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 6 541 6.949e-05 0.000601
539 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 7 799 6.971e-05 0.0006017
540 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 3 60 7.133e-05 0.0006135
541 OLIGODENDROCYTE DIFFERENTIATION 3 60 7.133e-05 0.0006135
542 REGULATION OF VIRAL TRANSCRIPTION 3 61 7.495e-05 0.0006434
543 NEGATIVE REGULATION OF CELL GROWTH 4 170 7.59e-05 0.0006504
544 CELLULAR RESPONSE TO HORMONE STIMULUS 6 552 7.767e-05 0.0006643
545 SOMITOGENESIS 3 62 7.869e-05 0.0006681
546 POSITIVE REGULATION OF NUCLEAR DIVISION 3 62 7.869e-05 0.0006681
547 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 3 62 7.869e-05 0.0006681
548 EMBRYONIC HEART TUBE MORPHOGENESIS 3 62 7.869e-05 0.0006681
549 PROTEIN LOCALIZATION TO ORGANELLE 6 556 8.083e-05 0.0006851
550 CELLULAR RESPONSE TO ACID CHEMICAL 4 175 8.493e-05 0.0007172
551 HOMEOSTASIS OF NUMBER OF CELLS 4 175 8.493e-05 0.0007172
552 RESPONSE TO CORTICOSTEROID 4 176 8.683e-05 0.0007319
553 CELLULAR RESPONSE TO RETINOIC ACID 3 65 9.064e-05 0.0007599
554 REGULATION OF CHEMOKINE PRODUCTION 3 65 9.064e-05 0.0007599
555 REGULATION OF RESPONSE TO OXIDATIVE STRESS 3 65 9.064e-05 0.0007599
556 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 3 66 9.487e-05 0.0007911
557 FOREBRAIN GENERATION OF NEURONS 3 66 9.487e-05 0.0007911
558 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 3 66 9.487e-05 0.0007911
559 POSITIVE REGULATION OF HORMONE METABOLIC PROCESS 2 11 9.581e-05 0.0007918
560 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 2 11 9.581e-05 0.0007918
561 RESPONSE TO FOLLICLE STIMULATING HORMONE 2 11 9.581e-05 0.0007918
562 PROSTATE GLAND GROWTH 2 11 9.581e-05 0.0007918
563 PROSTATE GLANDULAR ACINUS DEVELOPMENT 2 11 9.581e-05 0.0007918
564 RESPONSE TO KETONE 4 182 9.885e-05 0.0008155
565 POSITIVE REGULATION OF NEURON DEATH 3 67 9.922e-05 0.0008157
566 NEURON FATE COMMITMENT 3 67 9.922e-05 0.0008157
567 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 5 360 0.0001071 0.0008787
568 RESPONSE TO ACTIVITY 3 69 0.0001083 0.0008874
569 CARTILAGE MORPHOGENESIS 2 12 0.0001149 0.0009296
570 REGULATION OF VITAMIN METABOLIC PROCESS 2 12 0.0001149 0.0009296
571 REGULATION OF THYMOCYTE APOPTOTIC PROCESS 2 12 0.0001149 0.0009296
572 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 2 12 0.0001149 0.0009296
573 MYELOID CELL DIFFERENTIATION 4 189 0.0001144 0.0009296
574 POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION 2 12 0.0001149 0.0009296
575 NEGATIVE REGULATION OF RECEPTOR BINDING 2 12 0.0001149 0.0009296
576 GAMETE GENERATION 6 595 0.0001174 0.0009481
577 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 3 71 0.000118 0.0009496
578 CELL FATE SPECIFICATION 3 71 0.000118 0.0009496
579 REGULATION OF NEURON APOPTOTIC PROCESS 4 192 0.0001215 0.0009766
580 DEVELOPMENTAL MATURATION 4 193 0.000124 0.0009946
581 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 5 372 0.0001249 0.001
582 PANCREAS DEVELOPMENT 3 73 0.0001281 0.001023
583 REGULATION OF ORGAN GROWTH 3 73 0.0001281 0.001023
584 CELL CELL ADHESION 6 608 0.0001321 0.001053
585 NEURONAL STEM CELL DIVISION 2 13 0.0001356 0.001059
586 NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 2 13 0.0001356 0.001059
587 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 4 197 0.0001342 0.001059
588 LEFT RIGHT AXIS SPECIFICATION 2 13 0.0001356 0.001059
589 CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS 2 13 0.0001356 0.001059
590 HEART VALVE FORMATION 2 13 0.0001356 0.001059
591 CARDIOBLAST DIFFERENTIATION 2 13 0.0001356 0.001059
592 RESPONSE TO HEPATOCYTE GROWTH FACTOR 2 13 0.0001356 0.001059
593 NEUROBLAST DIVISION 2 13 0.0001356 0.001059
594 GLIAL CELL FATE COMMITMENT 2 13 0.0001356 0.001059
595 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 2 13 0.0001356 0.001059
596 NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 2 13 0.0001356 0.001059
597 ARTERY DEVELOPMENT 3 75 0.0001389 0.00108
598 BIOMINERAL TISSUE DEVELOPMENT 3 75 0.0001389 0.00108
599 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 4 199 0.0001395 0.001084
600 REGULATION OF INTRACELLULAR TRANSPORT 6 621 0.0001483 0.00115
601 CELL PROJECTION ORGANIZATION 7 902 0.0001489 0.001153
602 REGULATION OF BMP SIGNALING PATHWAY 3 77 0.0001502 0.001161
603 POSITIVE REGULATION OF HYDROLASE ACTIVITY 7 905 0.0001521 0.001173
604 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 2 14 0.0001581 0.001196
605 RENAL VESICLE DEVELOPMENT 2 14 0.0001581 0.001196
606 POSITIVE REGULATION OF MEIOTIC CELL CYCLE 2 14 0.0001581 0.001196
607 REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 4 205 0.0001564 0.001196
608 REGULATION OF GLOMERULUS DEVELOPMENT 2 14 0.0001581 0.001196
609 METANEPHRIC MESENCHYME DEVELOPMENT 2 14 0.0001581 0.001196
610 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 2 14 0.0001581 0.001196
611 REGULATION OF PROTEIN KINASE C SIGNALING 2 14 0.0001581 0.001196
612 NEURON PROJECTION GUIDANCE 4 205 0.0001564 0.001196
613 REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 2 14 0.0001581 0.001196
614 ADENOHYPOPHYSIS DEVELOPMENT 2 14 0.0001581 0.001196
615 MIDGUT DEVELOPMENT 2 14 0.0001581 0.001196
616 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 3 79 0.000162 0.001222
617 BONE MORPHOGENESIS 3 79 0.000162 0.001222
618 POSITIVE REGULATION OF MAP KINASE ACTIVITY 4 207 0.0001623 0.001222
619 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 3 80 0.0001682 0.001264
620 LYMPHOCYTE DIFFERENTIATION 4 209 0.0001684 0.001264
621 RESPONSE TO MECHANICAL STIMULUS 4 210 0.0001715 0.001285
622 POSITIVE REGULATION OF PROTEIN SECRETION 4 211 0.0001747 0.001305
623 REGULATION OF FIBROBLAST PROLIFERATION 3 81 0.0001745 0.001305
624 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 7 926 0.0001753 0.001307
625 MULTI MULTICELLULAR ORGANISM PROCESS 4 213 0.0001811 0.001348
626 POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 2 15 0.0001823 0.001351
627 OTIC VESICLE DEVELOPMENT 2 15 0.0001823 0.001351
628 POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS 2 15 0.0001823 0.001351
629 RESPONSE TO PEPTIDE 5 404 0.0001836 0.001358
630 POSITIVE REGULATION OF TRANSPORT 7 936 0.0001873 0.001384
631 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 4 216 0.0001911 0.001407
632 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 4 216 0.0001911 0.001407
633 TISSUE MIGRATION 3 84 0.0001944 0.001429
634 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 4 218 0.0001979 0.001453
635 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 3 85 0.0002013 0.001475
636 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 2 16 0.0002082 0.001511
637 MORPHOGENESIS OF AN ENDOTHELIUM 2 16 0.0002082 0.001511
638 ORGAN INDUCTION 2 16 0.0002082 0.001511
639 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 2 16 0.0002082 0.001511
640 ATRIOVENTRICULAR VALVE MORPHOGENESIS 2 16 0.0002082 0.001511
641 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 2 16 0.0002082 0.001511
642 CHROMATIN ORGANIZATION 6 663 0.0002117 0.001534
643 LEUKOCYTE PROLIFERATION 3 88 0.000223 0.001612
644 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 3 88 0.000223 0.001612
645 NEGATIVE REGULATION OF PHOSPHORYLATION 5 422 0.0002247 0.001621
646 REGULATION OF GTPASE ACTIVITY 6 673 0.0002295 0.001653
647 SEGMENTATION 3 89 0.0002306 0.001659
648 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 2 17 0.0002357 0.001677
649 CELLULAR RESPONSE TO LITHIUM ION 2 17 0.0002357 0.001677
650 REGULATION OF RECEPTOR BINDING 2 17 0.0002357 0.001677
651 ESTABLISHMENT OF TISSUE POLARITY 2 17 0.0002357 0.001677
652 NEGATIVE REGULATION OF ANOIKIS 2 17 0.0002357 0.001677
653 REGULATION OF STEM CELL POPULATION MAINTENANCE 2 17 0.0002357 0.001677
654 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 2 17 0.0002357 0.001677
655 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 3 90 0.0002384 0.001691
656 MIDBRAIN DEVELOPMENT 3 90 0.0002384 0.001691
657 RESPONSE TO DRUG 5 431 0.0002478 0.001755
658 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 4 232 0.0002511 0.001775
659 INNER EAR MORPHOGENESIS 3 92 0.0002543 0.001796
660 KIDNEY MESENCHYME DEVELOPMENT 2 18 0.000265 0.001868
661 REGULATION OF DNA BIOSYNTHETIC PROCESS 3 94 0.000271 0.001905
662 NEURAL TUBE FORMATION 3 94 0.000271 0.001905
663 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 3 95 0.0002796 0.001959
664 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 3 95 0.0002796 0.001959
665 MYELOID LEUKOCYTE DIFFERENTIATION 3 96 0.0002883 0.002014
666 CARDIOCYTE DIFFERENTIATION 3 96 0.0002883 0.002014
667 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 2 19 0.0002959 0.002055
668 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 2 19 0.0002959 0.002055
669 ATRIOVENTRICULAR VALVE DEVELOPMENT 2 19 0.0002959 0.002055
670 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 2 19 0.0002959 0.002055
671 POSITIVE REGULATION OF CELL CELL ADHESION 4 243 0.0002995 0.002077
672 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 3 98 0.0003064 0.002121
673 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 3 99 0.0003157 0.002173
674 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 3 99 0.0003157 0.002173
675 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 3 99 0.0003157 0.002173
676 RESPONSE TO CYTOKINE 6 714 0.0003156 0.002173
677 MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM 3 100 0.0003251 0.002231
678 LIMBIC SYSTEM DEVELOPMENT 3 100 0.0003251 0.002231
679 POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 2 20 0.0003285 0.002235
680 NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 2 20 0.0003285 0.002235
681 METANEPHRIC EPITHELIUM DEVELOPMENT 2 20 0.0003285 0.002235
682 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 2 20 0.0003285 0.002235
683 TONGUE DEVELOPMENT 2 20 0.0003285 0.002235
684 NEGATIVE REGULATION OF TRANSPORT 5 458 0.000328 0.002235
685 CELL DIVISION 5 460 0.0003346 0.002271
686 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 3 101 0.0003348 0.002271
687 CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 4 252 0.0003438 0.002325
688 REGULATION OF NEURON DEATH 4 252 0.0003438 0.002325
689 SEXUAL REPRODUCTION 6 730 0.0003555 0.0024
690 METANEPHRIC NEPHRON MORPHOGENESIS 2 21 0.0003628 0.002425
691 ECTODERM DEVELOPMENT 2 21 0.0003628 0.002425
692 CELL AGGREGATION 2 21 0.0003628 0.002425
693 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 2 21 0.0003628 0.002425
694 COCHLEA MORPHOGENESIS 2 21 0.0003628 0.002425
695 NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 2 21 0.0003628 0.002425
696 CARTILAGE CONDENSATION 2 21 0.0003628 0.002425
697 POSITIVE REGULATION OF PROTEIN IMPORT 3 104 0.0003648 0.002436
698 MACROMOLECULAR COMPLEX ASSEMBLY 8 1398 0.000373 0.002487
699 CEREBRAL CORTEX DEVELOPMENT 3 105 0.0003752 0.002498
700 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 4 258 0.0003759 0.002498
701 REGULATION OF IMMUNE SYSTEM PROCESS 8 1403 0.0003822 0.002537
702 FAT CELL DIFFERENTIATION 3 106 0.0003858 0.002557
703 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 2 22 0.0003987 0.002617
704 SEX DETERMINATION 2 22 0.0003987 0.002617
705 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 2 22 0.0003987 0.002617
706 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 2 22 0.0003987 0.002617
707 PROTEIN LOCALIZATION TO CELL SURFACE 2 22 0.0003987 0.002617
708 RESPONSE TO RETINOIC ACID 3 107 0.0003966 0.002617
709 PLATELET DEGRANULATION 3 107 0.0003966 0.002617
710 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 2 23 0.0004363 0.00284
711 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 2 23 0.0004363 0.00284
712 REGULATION OF OSTEOBLAST PROLIFERATION 2 23 0.0004363 0.00284
713 ADRENAL GLAND DEVELOPMENT 2 23 0.0004363 0.00284
714 REGULATION OF SUPEROXIDE METABOLIC PROCESS 2 23 0.0004363 0.00284
715 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 2 23 0.0004363 0.00284
716 NEGATIVE REGULATION OF DNA METABOLIC PROCESS 3 111 0.0004416 0.00287
717 CELL CYCLE PROCESS 7 1081 0.0004519 0.002932
718 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 2 24 0.0004756 0.003069
719 RESPONSE TO STEROL 2 24 0.0004756 0.003069
720 REGULATION OF ODONTOGENESIS 2 24 0.0004756 0.003069
721 REGULATION OF ANOIKIS 2 24 0.0004756 0.003069
722 REGULATION OF ENDOTHELIAL CELL MIGRATION 3 114 0.0004775 0.003077
723 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 5 498 0.0004812 0.003097
724 REGULATION OF CHROMOSOME ORGANIZATION 4 278 0.0004983 0.003202
725 REGULATION OF CYTOSKELETON ORGANIZATION 5 502 0.0004991 0.003203
726 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 2 25 0.0005165 0.003301
727 LUNG CELL DIFFERENTIATION 2 25 0.0005165 0.003301
728 SPECIFICATION OF SYMMETRY 3 117 0.0005151 0.003301
729 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 4 282 0.0005258 0.003356
730 DEVELOPMENTAL PROGRAMMED CELL DEATH 2 26 0.0005591 0.003535
731 NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 2 26 0.0005591 0.003535
732 HEART TRABECULA MORPHOGENESIS 2 26 0.0005591 0.003535
733 CYTOKINE PRODUCTION 3 120 0.0005546 0.003535
734 MESODERMAL CELL DIFFERENTIATION 2 26 0.0005591 0.003535
735 REGULATION OF P38MAPK CASCADE 2 26 0.0005591 0.003535
736 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 2 26 0.0005591 0.003535
737 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 4 289 0.0005766 0.00364
738 PROTEIN COMPLEX BIOGENESIS 7 1132 0.0005964 0.003755
739 PROTEIN COMPLEX ASSEMBLY 7 1132 0.0005964 0.003755
740 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 2 27 0.0006033 0.003768
741 POSITIVE REGULATION OF HEART GROWTH 2 27 0.0006033 0.003768
742 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 2 27 0.0006033 0.003768
743 LEUKOCYTE DIFFERENTIATION 4 292 0.0005993 0.003768
744 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 2 27 0.0006033 0.003768
745 SUBSTRATE DEPENDENT CELL MIGRATION 2 27 0.0006033 0.003768
746 STEROID HORMONE MEDIATED SIGNALING PATHWAY 3 125 0.0006247 0.003897
747 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 2 28 0.0006492 0.004022
748 GASTRULATION WITH MOUTH FORMING SECOND 2 28 0.0006492 0.004022
749 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 2 28 0.0006492 0.004022
750 MORPHOGENESIS OF A POLARIZED EPITHELIUM 2 28 0.0006492 0.004022
751 RESPONSE TO GONADOTROPIN 2 28 0.0006492 0.004022
752 NUCLEAR IMPORT 3 129 0.0006847 0.004231
753 CELL JUNCTION ASSEMBLY 3 129 0.0006847 0.004231
754 REGULATION OF MEIOTIC NUCLEAR DIVISION 2 29 0.0006967 0.004277
755 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 2 29 0.0006967 0.004277
756 EMBRYONIC HINDLIMB MORPHOGENESIS 2 29 0.0006967 0.004277
757 REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 2 29 0.0006967 0.004277
758 NEUROBLAST PROLIFERATION 2 29 0.0006967 0.004277
759 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 6 829 0.0006979 0.004279
760 PROTEIN EXPORT FROM NUCLEUS 2 30 0.0007459 0.004548
761 ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY 2 30 0.0007459 0.004548
762 RESPONSE TO EPIDERMAL GROWTH FACTOR 2 30 0.0007459 0.004548
763 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 2 30 0.0007459 0.004548
764 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 3 133 0.0007482 0.004557
765 PEPTIDYL AMINO ACID MODIFICATION 6 841 0.0007527 0.004578
766 REGULATION OF ACTIN FILAMENT BASED PROCESS 4 312 0.000768 0.004665
767 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 3 135 0.0007813 0.00474
768 HYALURONAN METABOLIC PROCESS 2 31 0.0007966 0.004808
769 CARDIAC ATRIUM DEVELOPMENT 2 31 0.0007966 0.004808
770 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 2 31 0.0007966 0.004808
771 CELLULAR RESPONSE TO STRESS 8 1565 0.000795 0.004808
772 REGULATION OF CELL PROJECTION ORGANIZATION 5 558 0.0008058 0.004857
773 HINDBRAIN DEVELOPMENT 3 137 0.0008154 0.004902
774 ACTIVATION OF MAPK ACTIVITY 3 137 0.0008154 0.004902
775 INTRACELLULAR SIGNAL TRANSDUCTION 8 1572 0.0008188 0.004916
776 RESPONSE TO NITROGEN COMPOUND 6 859 0.0008409 0.005042
777 POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION 2 32 0.000849 0.005058
778 PATTERNING OF BLOOD VESSELS 2 32 0.000849 0.005058
779 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 2 32 0.000849 0.005058
780 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 2 32 0.000849 0.005058
781 METANEPHRIC NEPHRON DEVELOPMENT 2 32 0.000849 0.005058
782 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 4 321 0.0008538 0.00508
783 CELL ACTIVATION 5 568 0.0008728 0.005187
784 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 3 141 0.0008863 0.00526
785 REGULATION OF MYELINATION 2 33 0.0009031 0.005332
786 RESPONSE TO VITAMIN D 2 33 0.0009031 0.005332
787 POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 2 33 0.0009031 0.005332
788 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 2 33 0.0009031 0.005332
789 EPIDERMAL CELL DIFFERENTIATION 3 142 0.0009046 0.005335
790 CELLULAR RESPONSE TO OXYGEN LEVELS 3 143 0.0009231 0.005437
791 FOREBRAIN NEURON DEVELOPMENT 2 34 0.0009587 0.005625
792 PROTEIN KINASE B SIGNALING 2 34 0.0009587 0.005625
793 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 2 34 0.0009587 0.005625
794 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 3 145 0.000961 0.005632
795 RESPONSE TO BIOTIC STIMULUS 6 886 0.0009883 0.005784
796 NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 2 35 0.001016 0.005909
797 BONE REMODELING 2 35 0.001016 0.005909
798 HAIR CELL DIFFERENTIATION 2 35 0.001016 0.005909
799 NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 2 35 0.001016 0.005909
800 REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 2 35 0.001016 0.005909
801 PEPTIDYL SERINE MODIFICATION 3 148 0.00102 0.005915
802 SECRETION 5 588 0.001019 0.005915
803 CHROMATIN REMODELING 3 150 0.00106 0.006141
804 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 2 36 0.001075 0.006205
805 POSITIVE REGULATION OF PROTEIN ACETYLATION 2 36 0.001075 0.006205
806 POSITIVE CHEMOTAXIS 2 36 0.001075 0.006205
807 LYMPHOCYTE ACTIVATION 4 342 0.00108 0.006229
808 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 3 152 0.001101 0.006341
809 HINDLIMB MORPHOGENESIS 2 37 0.001135 0.006498
810 MYOBLAST DIFFERENTIATION 2 37 0.001135 0.006498
811 GLIAL CELL MIGRATION 2 37 0.001135 0.006498
812 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 2 37 0.001135 0.006498
813 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 2 37 0.001135 0.006498
814 CELL CYCLE ARREST 3 154 0.001143 0.006536
815 PROTEIN IMPORT 3 155 0.001165 0.00665
816 CELLULAR RESPONSE TO CYTOKINE STIMULUS 5 606 0.001166 0.00665
817 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 3 156 0.001187 0.006758
818 OOCYTE DIFFERENTIATION 2 38 0.001197 0.006794
819 POSITIVE REGULATION OF ORGAN GROWTH 2 38 0.001197 0.006794
820 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 2 38 0.001197 0.006794
821 HORMONE MEDIATED SIGNALING PATHWAY 3 158 0.001231 0.006968
822 REGULATION OF DEPHOSPHORYLATION 3 158 0.001231 0.006968
823 NUCLEAR TRANSPORT 4 355 0.00124 0.007011
824 POSITIVE REGULATION OF VIRAL TRANSCRIPTION 2 39 0.001261 0.007061
825 NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 2 39 0.001261 0.007061
826 ANATOMICAL STRUCTURE MATURATION 2 39 0.001261 0.007061
827 TRABECULA MORPHOGENESIS 2 39 0.001261 0.007061
828 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 2 39 0.001261 0.007061
829 ASTROCYTE DIFFERENTIATION 2 39 0.001261 0.007061
830 COCHLEA DEVELOPMENT 2 39 0.001261 0.007061
831 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 2 39 0.001261 0.007061
832 CELL CHEMOTAXIS 3 162 0.001323 0.007382
833 REGULATION OF MEIOTIC CELL CYCLE 2 40 0.001326 0.007382
834 ENDOCRINE PANCREAS DEVELOPMENT 2 40 0.001326 0.007382
835 ENDODERMAL CELL DIFFERENTIATION 2 40 0.001326 0.007382
836 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 2 40 0.001326 0.007382
837 POSITIVE REGULATION OF HEMOPOIESIS 3 163 0.001346 0.007485
838 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 4 365 0.001374 0.007628
839 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 2 41 0.001393 0.007717
840 LUNG ALVEOLUS DEVELOPMENT 2 41 0.001393 0.007717
841 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 3 166 0.001419 0.007849
842 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 4 370 0.001444 0.007972
843 POSITIVE REGULATION OF SECRETION 4 370 0.001444 0.007972
844 CELL CYCLE 7 1316 0.001452 0.008006
845 POSITIVE REGULATION OF DNA BINDING 2 42 0.001462 0.008039
846 EPITHELIAL CELL MORPHOGENESIS 2 42 0.001462 0.008039
847 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 2 43 0.001532 0.008384
848 MORPHOGENESIS OF AN EPITHELIAL SHEET 2 43 0.001532 0.008384
849 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 2 43 0.001532 0.008384
850 BETA CATENIN TCF COMPLEX ASSEMBLY 2 43 0.001532 0.008384
851 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 3 171 0.001545 0.008446
852 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 3 172 0.001571 0.008568
853 REGULATION OF CELL SIZE 3 172 0.001571 0.008568
854 STRIATED MUSCLE CELL DIFFERENTIATION 3 173 0.001597 0.008701
855 LABYRINTHINE LAYER DEVELOPMENT 2 44 0.001603 0.008725
856 THYMOCYTE AGGREGATION 2 45 0.001676 0.009102
857 T CELL DIFFERENTIATION IN THYMUS 2 45 0.001676 0.009102
858 REGULATION OF PROTEIN SECRETION 4 389 0.001735 0.009411
859 NEGATIVE REGULATION OF DNA BINDING 2 46 0.001751 0.009453
860 PEPTIDYL THREONINE MODIFICATION 2 46 0.001751 0.009453
861 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 2 46 0.001751 0.009453
862 REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH 2 46 0.001751 0.009453
863 REGULATION OF CHEMOTAXIS 3 180 0.001789 0.009644
864 THYMUS DEVELOPMENT 2 47 0.001827 0.009819
865 POSITIVE REGULATION OF DEPHOSPHORYLATION 2 47 0.001827 0.009819
866 POSITIVE REGULATION OF GLIOGENESIS 2 47 0.001827 0.009819
867 POSITIVE REGULATION OF CATABOLIC PROCESS 4 395 0.001835 0.009849
NumGOOverlapSizeP ValueAdj. P Value
1 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 6 50 5.09e-11 3.387e-08
2 RECEPTOR BINDING 15 1476 7.291e-11 3.387e-08
3 SMAD BINDING 5 72 3.985e-08 1.234e-05
4 CHROMATIN BINDING 8 435 7.255e-08 1.576e-05
5 MACROMOLECULAR COMPLEX BINDING 12 1399 8.481e-08 1.576e-05
6 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 5 90 1.231e-07 1.906e-05
7 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 11 1199 1.836e-07 2.437e-05
8 REGULATORY REGION NUCLEIC ACID BINDING 9 818 7.393e-07 8.585e-05
9 PROTEIN KINASE ACTIVITY 8 640 1.363e-06 0.0001268
10 CYTOKINE RECEPTOR BINDING 6 271 1.365e-06 0.0001268
11 PROTEIN HETERODIMERIZATION ACTIVITY 7 468 2.174e-06 0.0001683
12 GROWTH FACTOR ACTIVITY 5 160 2.155e-06 0.0001683
13 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 6 328 4.114e-06 0.000294
14 TRANSCRIPTION FACTOR BINDING 7 524 4.585e-06 0.0003043
15 SEQUENCE SPECIFIC DNA BINDING 9 1037 5.252e-06 0.0003253
16 KINASE ACTIVITY 8 842 1.038e-05 0.0005358
17 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 7 588 9.747e-06 0.0005358
18 CYTOKINE ACTIVITY 5 219 9.976e-06 0.0005358
19 PROTEIN DIMERIZATION ACTIVITY 9 1149 1.207e-05 0.0005901
20 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 7 629 1.51e-05 0.0006727
21 FRIZZLED BINDING 3 36 1.521e-05 0.0006727
22 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 8 992 3.398e-05 0.001435
23 ENZYME BINDING 10 1737 5.049e-05 0.002039
24 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 5 315 5.702e-05 0.002207
25 I SMAD BINDING 2 11 9.581e-05 0.00356
26 KINASE BINDING 6 606 0.0001298 0.004636
27 PROTEIN DOMAIN SPECIFIC BINDING 6 624 0.0001522 0.005238
28 C2H2 ZINC FINGER DOMAIN BINDING 2 14 0.0001581 0.005246
29 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 3 81 0.0001745 0.005292
30 RECEPTOR SERINE THREONINE KINASE BINDING 2 15 0.0001823 0.005292
31 PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 2 15 0.0001823 0.005292
32 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR 2 15 0.0001823 0.005292
33 BETA CATENIN BINDING 3 84 0.0001944 0.005472
34 TRANSFORMING GROWTH FACTOR BETA BINDING 2 16 0.0002082 0.005525
35 RECEPTOR AGONIST ACTIVITY 2 16 0.0002082 0.005525
36 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 4 226 0.0002272 0.005862
37 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 2 17 0.0002357 0.005919
38 CYTOKINE BINDING 3 92 0.0002543 0.006218
39 MOLECULAR FUNCTION REGULATOR 8 1353 0.0002986 0.006765
40 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS 2 19 0.0002959 0.006765
41 PROTEIN SERINE THREONINE KINASE ACTIVITY 5 445 0.0002872 0.006765
42 DNA BINDING BENDING 2 20 0.0003285 0.007266
43 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 3 105 0.0003752 0.008107
44 IONOTROPIC GLUTAMATE RECEPTOR BINDING 2 23 0.0004363 0.009008
45 FIBROBLAST GROWTH FACTOR BINDING 2 23 0.0004363 0.009008
46 DOUBLE STRANDED DNA BINDING 6 764 0.0004532 0.009152
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 9 426 2.768e-09 1.617e-06
2 EXTRACELLULAR SPACE 12 1376 7.064e-08 2.063e-05
3 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 5 127 6.884e-07 0.000134
4 TRANSCRIPTION FACTOR COMPLEX 6 298 2.367e-06 0.0003455
5 CELL SURFACE 8 757 4.753e-06 0.0005551
6 PROTEINACEOUS EXTRACELLULAR MATRIX 6 356 6.581e-06 0.0006405
7 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 4 101 9.833e-06 0.0008203
8 PLATELET ALPHA GRANULE LUMEN 3 55 5.493e-05 0.00401
9 WNT SIGNALOSOME 2 11 9.581e-05 0.006217
10 PLATELET ALPHA GRANULE 3 75 0.0001389 0.008109
11 BETA CATENIN DESTRUCTION COMPLEX 2 14 0.0001581 0.008395
12 SECRETORY GRANULE LUMEN 3 85 0.0002013 0.009796

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04390_Hippo_signaling_pathway 12 154 4.422e-19 7.96e-17
2 hsa04340_Hedgehog_signaling_pathway 6 56 1.034e-10 9.309e-09
3 hsa04350_TGF.beta_signaling_pathway 6 85 1.357e-09 8.144e-08
4 hsa04916_Melanogenesis 6 101 3.877e-09 1.745e-07
5 hsa04520_Adherens_junction 5 73 4.274e-08 1.306e-06
6 hsa04310_Wnt_signaling_pathway 6 151 4.353e-08 1.306e-06
7 hsa04144_Endocytosis 4 203 0.0001506 0.003872
8 hsa04010_MAPK_signaling_pathway 4 268 0.000434 0.009765
9 hsa04110_Cell_cycle 3 128 0.0006694 0.01205
10 hsa04380_Osteoclast_differentiation 3 128 0.0006694 0.01205
11 hsa04510_Focal_adhesion 3 200 0.002414 0.0395
12 hsa04151_PI3K_AKT_signaling_pathway 3 351 0.01147 0.1721
13 hsa04014_Ras_signaling_pathway 2 236 0.04011 0.5156

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1 LINC00941 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-340-5p;hsa-miR-497-5p;hsa-miR-532-5p 17 HMGA2 Sponge network 4.292 0 4.457 0 0.69
2

MAGI2-AS3

 hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-224-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30c-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-651-5p;hsa-miR-7-1-3p;hsa-miR-944 12 HGF Sponge network -0.939 4.0E-5 -0.629 0.02489 0.681
3 RP11-221N13.3 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-20b-5p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-664a-5p 15 HMGA2 Sponge network 5.876 0 4.457 0 0.612
4 AC007879.7 hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-340-5p 15 HMGA2 Sponge network 2.7 0 4.457 0 0.545
5 DNM3OS hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-224-3p;hsa-miR-26b-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-651-5p;hsa-miR-7-1-3p;hsa-miR-944 11 HGF Sponge network 0.932 0.00442 -0.629 0.02489 0.521
6 RP11-462L8.1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-34a-5p;hsa-miR-532-5p 11 HMGA2 Sponge network 4.262 0 4.457 0 0.518
7 RP11-218E20.3 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-337-3p;hsa-miR-381-3p;hsa-miR-491-5p;hsa-miR-497-5p;hsa-miR-532-5p 26 HMGA2 Sponge network 4.613 0 4.457 0 0.517
8

RP11-166D19.1

 hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-224-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-651-5p;hsa-miR-7-1-3p;hsa-miR-944 10 HGF Sponge network -0.882 5.0E-5 -0.629 0.02489 0.51
9 RP11-445F12.1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-340-5p;hsa-miR-491-5p;hsa-miR-497-5p;hsa-miR-664a-5p 15 HMGA2 Sponge network 7.107 0 4.457 0 0.508
10 TPTEP1 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-339-5p;hsa-miR-424-5p;hsa-miR-455-5p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-944 18 TGFBR3 Sponge network -2.193 0 -2.338 0 0.503
11 RP11-890B15.2 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-34a-5p;hsa-miR-497-5p;hsa-miR-532-5p 16 HMGA2 Sponge network 4.029 0 4.457 0 0.474
12 CTD-2587H24.5 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-23b-3p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-491-5p;hsa-miR-497-5p;hsa-miR-664a-5p 16 HMGA2 Sponge network 7.138 0 4.457 0 0.472
13 LINC00704 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-491-5p;hsa-miR-532-5p;hsa-miR-664a-5p 15 HMGA2 Sponge network 2.465 0 4.457 0 0.464
14 SNHG14 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-455-5p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-944 13 TGFBR3 Sponge network -1.125 0.0001 -2.338 0 0.457
15 RP11-417E7.1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-491-5p;hsa-miR-532-5p 13 HMGA2 Sponge network 3.987 0 4.457 0 0.455
16 CTD-2357A8.3 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-199b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-34a-5p 10 HMGA2 Sponge network 7.162 0 4.457 0 0.455
17 LINC00911 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-491-5p 11 HMGA2 Sponge network 4.956 0 4.457 0 0.454
18 TTLL11-IT1 hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-199b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p 10 HMGA2 Sponge network 5.5 0 4.457 0 0.454
19

APCDD1L-AS1

 hsa-miR-107;hsa-miR-126-5p;hsa-miR-140-5p;hsa-miR-148b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-375;hsa-miR-532-5p;hsa-miR-9-5p 11 SNAI2 Sponge network 2.077 0 1.574 0 0.453
20 RP11-346D19.1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-340-5p 11 HMGA2 Sponge network 6.549 0 4.457 0 0.453
21 VPS9D1-AS1 hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 1.07 1.0E-5 4.457 0 0.453
22 RP5-884M6.1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-337-3p;hsa-miR-381-3p;hsa-miR-664a-5p 18 HMGA2 Sponge network 6.548 0 4.457 0 0.452
23 LINC00460 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-491-5p;hsa-miR-497-5p;hsa-miR-532-5p;hsa-miR-664a-5p 17 HMGA2 Sponge network 7.222 0 4.457 0 0.45
24

MAGI2-AS3

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-339-5p;hsa-miR-3607-3p;hsa-miR-424-5p;hsa-miR-455-5p;hsa-miR-589-3p;hsa-miR-7-1-3p;hsa-miR-944 19 TGFBR3 Sponge network -0.939 4.0E-5 -2.338 0 0.449
25 RAMP2-AS1 hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-339-5p;hsa-miR-424-5p;hsa-miR-455-5p;hsa-miR-484;hsa-miR-589-3p 13 TGFBR3 Sponge network -1.258 0.00026 -2.338 0 0.448
26 RP13-463N16.6 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-148a-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p 10 HMGA2 Sponge network 3.312 0 4.457 0 0.446
27 RP11-30P6.6 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-491-5p 17 HMGA2 Sponge network 2.847 0 4.457 0 0.439
28 RP1-193H18.2 hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-589-3p;hsa-miR-944 11 TGFBR3 Sponge network -1.539 0 -2.338 0 0.438
29 AC005682.5 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-340-5p;hsa-miR-664a-5p 15 HMGA2 Sponge network 1.074 0 4.457 0 0.434
30 RP11-150O12.1 hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-532-5p;hsa-miR-664a-5p 16 HMGA2 Sponge network 1.523 0 4.457 0 0.432
31

SH3RF3-AS1

 hsa-let-7a-3p;hsa-miR-148b-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-193a-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-29b-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-576-5p;hsa-miR-7-1-3p 13 LIMS1 Sponge network -0.175 0.58985 0.197 0.25634 0.431
32

MAGI2-AS3

 hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-149-5p;hsa-miR-200a-3p;hsa-miR-29b-3p;hsa-miR-33a-3p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-500a-5p;hsa-miR-500b-5p;hsa-miR-589-3p;hsa-miR-944 13 TGFB2 Sponge network -0.939 4.0E-5 0.078 0.72302 0.43
33 RP11-879F14.2 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p 15 HMGA2 Sponge network 1.149 9.0E-5 4.457 0 0.422
34 RP11-1020M18.10 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-497-5p;hsa-miR-664a-5p 12 HMGA2 Sponge network 6.911 0 4.457 0 0.415
35 ZNF667-AS1 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-424-5p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-590-5p 14 TGFBR3 Sponge network -1.395 0 -2.338 0 0.412
36 LINC00958 hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-340-5p;hsa-miR-497-5p;hsa-miR-664a-5p 13 HMGA2 Sponge network 1.836 0 4.457 0 0.41
37 LINC00518 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-664a-5p 14 HMGA2 Sponge network 2.747 4.0E-5 4.457 0 0.41
38 KTN1-AS1 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-34a-5p;hsa-miR-532-5p 16 HMGA2 Sponge network 1.107 0 4.457 0 0.408
39 AC007743.1 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-339-5p;hsa-miR-424-5p;hsa-miR-455-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 16 TGFBR3 Sponge network -1.053 0.00923 -2.338 0 0.405
40 CTD-2066L21.3 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p 15 HMGA2 Sponge network 5.449 0 4.457 0 0.402
41 RP11-13K12.5 hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-339-5p;hsa-miR-424-5p;hsa-miR-589-3p 10 TGFBR3 Sponge network -0.552 0.43847 -2.338 0 0.399
42

RP4-798P15.3

 hsa-let-7a-3p;hsa-miR-148b-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-193a-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-576-5p;hsa-miR-7-1-3p;hsa-miR-96-5p 11 LIMS1 Sponge network -1.213 0.00098 0.197 0.25634 0.399
43 LINC01018 hsa-miR-15a-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-944 11 TGFBR3 Sponge network -1.613 0.00396 -2.338 0 0.398
44 AL035610.1 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-424-5p 12 TGFBR3 Sponge network -5.893 0 -2.338 0 0.398
45 CTD-2555C10.3 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-491-5p;hsa-miR-664a-3p 16 HMGA2 Sponge network 1.037 0.0004 4.457 0 0.397
46

LINC00702

 hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-149-5p;hsa-miR-200a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-500a-5p;hsa-miR-500b-5p;hsa-miR-589-3p;hsa-miR-590-5p 10 TGFB2 Sponge network -0.573 0.0699 0.078 0.72302 0.396
47 PWAR6 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-455-5p;hsa-miR-589-3p;hsa-miR-944 12 TGFBR3 Sponge network -1.629 0 -2.338 0 0.395
48 NOP14-AS1 hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-340-5p;hsa-miR-34a-5p;hsa-miR-491-5p;hsa-miR-497-5p;hsa-miR-664a-5p 24 HMGA2 Sponge network 0.939 0 4.457 0 0.392
49 SOX21-AS1 hsa-miR-15a-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-29a-5p;hsa-miR-424-5p;hsa-miR-455-5p 11 TGFBR3 Sponge network -1.061 0.01562 -2.338 0 0.391
50

MAGI2-AS3

 hsa-let-7a-3p;hsa-miR-148b-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-193a-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-29b-3p;hsa-miR-30c-5p;hsa-miR-3607-3p;hsa-miR-429;hsa-miR-505-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 16 LIMS1 Sponge network -0.939 4.0E-5 0.197 0.25634 0.387
51

CASC15

 hsa-miR-142-3p;hsa-miR-155-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-3p;hsa-miR-26b-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 14 WNT5A Sponge network 1.485 0 0.23 0.27604 0.383
52 LINC00707 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-340-5p;hsa-miR-34a-5p;hsa-miR-491-5p;hsa-miR-497-5p;hsa-miR-664a-3p;hsa-miR-664a-5p 24 HMGA2 Sponge network 2.018 1.0E-5 4.457 0 0.383
53 RP11-297P16.4 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p 15 HMGA2 Sponge network 7.048 0 4.457 0 0.379
54 AC108142.1 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-34a-5p;hsa-miR-664a-5p 12 HMGA2 Sponge network 2.31 0 4.457 0 0.378
55

CTD-2015G9.2

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-505-5p;hsa-miR-576-5p 10 EPB41L5 Sponge network -3.112 5.0E-5 -0.492 9.0E-5 0.378
56 XXyac-YX65C7_A.3 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-195-3p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-5p;hsa-miR-30e-5p 14 HMGA2 Sponge network 6.112 0 4.457 0 0.374
57 RP11-42I10.1 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p 11 HMGA2 Sponge network 2.1 0 4.457 0 0.374
58

CTD-2269F5.1

 hsa-miR-142-3p;hsa-miR-155-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-29a-5p;hsa-miR-576-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p 11 WNT5A Sponge network -0.168 0.67173 0.23 0.27604 0.371
59 KB-1732A1.1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-491-5p;hsa-miR-497-5p 16 HMGA2 Sponge network 1.697 0 4.457 0 0.366
60 CTD-2354A18.1 hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-199b-5p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-34a-5p;hsa-miR-381-3p 13 HMGA2 Sponge network 4.214 0 4.457 0 0.364
61 RP11-366H4.1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-340-5p;hsa-miR-497-5p;hsa-miR-664a-5p 13 HMGA2 Sponge network 4.872 0 4.457 0 0.363
62 CTD-2171N6.1 hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-34a-5p;hsa-miR-497-5p 17 HMGA2 Sponge network 5.89 0 4.457 0 0.363
63 RP11-863P13.3 hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p 11 HMGA2 Sponge network 4.189 0 4.457 0 0.361
64

SH3RF3-AS1

 hsa-let-7a-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-576-5p;hsa-miR-582-5p;hsa-miR-7-1-3p 13 WNT5A Sponge network -0.175 0.58985 0.23 0.27604 0.358
65 RP11-357H14.17 hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-23b-3p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 8.011 0 4.457 0 0.357
66

FZD10-AS1

 hsa-let-7a-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-330-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p 13 WNT5A Sponge network -0.218 0.34607 0.23 0.27604 0.354
67 RP11-321G12.1 hsa-miR-15a-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-484;hsa-miR-589-3p 11 TGFBR3 Sponge network -3.552 0 -2.338 0 0.352
68

RP4-798P15.3

 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-339-5p;hsa-miR-455-5p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-944 16 TGFBR3 Sponge network -1.213 0.00098 -2.338 0 0.35
69 LINC00152 hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-497-5p;hsa-miR-532-5p 15 HMGA2 Sponge network 1.218 0 4.457 0 0.349
70 MIR4435-1HG hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-497-5p;hsa-miR-532-5p 10 HMGA2 Sponge network 1.225 0 4.457 0 0.343
71 AC011738.4 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-34a-5p;hsa-miR-497-5p;hsa-miR-532-5p;hsa-miR-664a-3p;hsa-miR-664a-5p 15 HMGA2 Sponge network 3.153 0 4.457 0 0.342
72 LINC00284 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-424-5p;hsa-miR-455-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-944 13 TGFBR3 Sponge network -4.159 0 -2.338 0 0.341
73 CTD-2554C21.3 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-455-5p 10 TGFBR3 Sponge network -2.118 6.0E-5 -2.338 0 0.34
74 RP11-384L8.1 hsa-miR-15a-5p;hsa-miR-16-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-424-5p;hsa-miR-484 13 TGFBR3 Sponge network -1.152 0.00016 -2.338 0 0.339
75 FAM66C hsa-miR-15a-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-424-5p;hsa-miR-484;hsa-miR-944 10 TGFBR3 Sponge network -0.798 0.00038 -2.338 0 0.338
76 RP11-479G22.8 hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p 11 HMGA2 Sponge network 0.955 0 4.457 0 0.335
77

CTD-2008P7.9

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-181a-2-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-424-5p;hsa-miR-576-5p 11 EPB41L5 Sponge network -1.202 0.00093 -0.492 9.0E-5 0.334
78 DLGAP1-AS5 hsa-miR-15a-5p;hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-455-5p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-944 12 TGFBR3 Sponge network -6.207 0 -2.338 0 0.331
79

AC003090.1

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-424-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 13 TGFBR3 Sponge network -4.323 0 -2.338 0 0.331
80 RP11-483L5.1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 2.236 1.0E-5 4.457 0 0.33
81 RP11-297P16.3 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-340-5p 15 HMGA2 Sponge network 6.381 0 4.457 0 0.328
82 HOTAIR hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-337-3p 14 HMGA2 Sponge network 7 0 4.457 0 0.326
83 LINC00639 hsa-miR-15a-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-424-5p;hsa-miR-484;hsa-miR-589-3p 10 TGFBR3 Sponge network -0.91 0.00848 -2.338 0 0.325
84 RP11-161I6.2 hsa-let-7c-5p;hsa-miR-148a-5p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-340-5p;hsa-miR-664a-5p 10 HMGA2 Sponge network 3.332 0 4.457 0 0.323
85 CTA-384D8.35 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-664a-5p 12 HMGA2 Sponge network 3.12 0 4.457 0 0.319
86 RP11-386G11.5 hsa-let-7c-5p;hsa-miR-125b-5p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-337-3p;hsa-miR-381-3p 10 HMGA2 Sponge network 4.247 0 4.457 0 0.319
87 AC005042.4 hsa-miR-15a-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-455-5p 10 TGFBR3 Sponge network -0.876 0.0183 -2.338 0 0.319
88

HHIP-AS1

 hsa-let-7a-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-29a-5p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p 12 WNT5A Sponge network -1.293 0.01561 0.23 0.27604 0.315
89 RP11-227H15.4 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-34a-5p;hsa-miR-497-5p 16 HMGA2 Sponge network 4.405 0 4.457 0 0.315
90 LINC00520 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-497-5p 13 HMGA2 Sponge network 3.383 0 4.457 0 0.313
91 RP11-78C3.1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-199b-5p;hsa-miR-20b-5p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-337-3p 18 HMGA2 Sponge network 5.978 0 4.457 0 0.311
92 RP11-285E9.6 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-199b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-491-5p;hsa-miR-497-5p;hsa-miR-664a-5p 15 HMGA2 Sponge network 1.44 1.0E-5 4.457 0 0.308
93 PART1 hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-455-5p 10 TGFBR3 Sponge network -3.265 0 -2.338 0 0.306
94 SSTR5-AS1 hsa-miR-15a-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-484 10 TGFBR3 Sponge network -1.443 0.04871 -2.338 0 0.303
95 FLG-AS1 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-7-1-3p 11 TGFBR3 Sponge network -1.901 0 -2.338 0 0.302
96 RP11-783K16.13 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-23b-3p;hsa-miR-30a-3p;hsa-miR-491-5p 10 HMGA2 Sponge network 0.411 0.01987 4.457 0 0.302
97 ADIRF-AS1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-664a-5p 15 HMGA2 Sponge network 1.011 0 4.457 0 0.299
98 RP11-774O3.3 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-424-5p;hsa-miR-589-3p;hsa-miR-7-1-3p;hsa-miR-944 12 TGFBR3 Sponge network -1.712 0 -2.338 0 0.298
99 RP5-1185I7.1 hsa-miR-15a-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-424-5p 10 TGFBR3 Sponge network -1.805 0.01092 -2.338 0 0.296
100 LINC00957 hsa-miR-15a-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-455-5p;hsa-miR-484 11 TGFBR3 Sponge network -0.677 2.0E-5 -2.338 0 0.294
101

LINC00900

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-424-5p;hsa-miR-455-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 15 TGFBR3 Sponge network -1.803 0 -2.338 0 0.294
102 RP11-815I9.4 hsa-miR-15a-5p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-29a-5p;hsa-miR-589-3p;hsa-miR-590-5p 10 TGFBR3 Sponge network 0.004 0.98116 -2.338 0 0.293
103 AC108676.1 hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-381-3p;hsa-miR-497-5p 11 HMGA2 Sponge network 7.672 0 4.457 0 0.292
104 RP6-91H8.3 hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-497-5p;hsa-miR-532-5p 13 HMGA2 Sponge network 3.796 0 4.457 0 0.292
105

MAGI2-AS3

 hsa-let-7a-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30c-5p;hsa-miR-330-5p;hsa-miR-576-5p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p 16 WNT5A Sponge network -0.939 4.0E-5 0.23 0.27604 0.291
106 HCG22 hsa-miR-15b-5p;hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-455-5p;hsa-miR-7-1-3p 10 TGFBR3 Sponge network -4.567 0 -2.338 0 0.286
107 RP11-379B18.5 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-381-3p;hsa-miR-664a-5p 18 HMGA2 Sponge network 1.569 0 4.457 0 0.285
108 FOXD2-AS1 hsa-let-7b-5p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p 10 HMGA2 Sponge network 2.446 0 4.457 0 0.276
109 RP11-757G1.6 hsa-miR-15a-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-424-5p;hsa-miR-589-3p;hsa-miR-944 11 TGFBR3 Sponge network -1.346 0.00088 -2.338 0 0.276
110 RP11-598F7.6 hsa-let-7c-5p;hsa-miR-125b-5p;hsa-miR-195-5p;hsa-miR-199b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-497-5p 10 HMGA2 Sponge network 4.086 0 4.457 0 0.273
111 AC006262.4 hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-497-5p 13 HMGA2 Sponge network 1.721 0.01526 4.457 0 0.271
112 RP11-848P1.4 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30a-5p 10 HMGA2 Sponge network 2.864 0 4.457 0 0.268
113

RP11-166D19.1

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-944 15 TGFBR3 Sponge network -0.882 5.0E-5 -2.338 0 0.267
114 AC144831.1 hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-7-1-3p 10 TGFBR3 Sponge network -1.546 0 -2.338 0 0.266
115

HHIP-AS1

 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-29a-5p;hsa-miR-455-5p;hsa-miR-7-1-3p;hsa-miR-944 10 TGFBR3 Sponge network -1.293 0.01561 -2.338 0 0.264
116 LINC00865 hsa-miR-15a-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-339-5p;hsa-miR-424-5p 10 TGFBR3 Sponge network -0.336 0.22355 -2.338 0 0.259
117

APCDD1L-AS1

 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-497-5p;hsa-miR-532-5p;hsa-miR-664a-5p 13 HMGA2 Sponge network 2.077 0 4.457 0 0.256
118 LUCAT1 hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-532-5p 13 HMGA2 Sponge network 1.475 0 4.457 0 0.25

Quest ID: 12169bc67b6f7393bd794bc39692a052